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Caspases activation has been established as one of the hallmarks of apoptosis. 
Nevertheless, non-apoptotic roles of caspases, particularly in vital processes such as 
cellular differentiation, cell signalling, and cellular remodelling have also been 
documented in recent years. 
 
In the first part of the study, we compared the effect of caspase 3 activation in cells 
exposed to a non-toxic dose (50µM) of the oxidative stress inducer, hydrogen 
peroxide (H2O2) to a classical inducer of apoptotic cell death, staurosporine (STS). 
Our results show that both treatments resulted in activation of caspase 3. Exposure to 
STS correlated with cell death that was accompanied by the activation of classical 
apoptotic pathway. On the contrary, activation of caspase 3 by H2O2 had no effect on 
the cells’ nucleus morphology and no significant increase in numbers of cells in sub-
G1 population. Instead, the cells underwent cell growth arrest up to 72h post-H2O2 
treatment. While STS activated caspase 3 through the well-established initiator 
caspase cascade pathway, activation of caspase 3 by H2O2 was independent of the 
initiator caspases. Although STS-activated caspase 3 could transitorily be detected in 
the cells’ nucleus, it ultimately accumulated in the cytosol. In contrast, a sustained 
nuclear localization of activated caspase 3 was observed in H2O2-treated cells. 
  
The second part of the study outlined an unconventional, lysosome-mediated pathway 
of caspase 3 activation. At 2-4h post-H2O2 treatment, lysosomal membrane 
permeabilization (LMP) was observed. In conjunction with this finding, lysosomal 
proteases cathepsin B and L were identified as possible upstream activators of caspase 
3. Cathepsin inhibitors zFA-FMK and zFY-CHO prevented cleavage and activation of 
vi 
 
caspase 3. Iron, peroxynitrite, nitric oxide and p53 were also identified to be upstream 
factors of LMP and cathepsin-mediated cleavage of caspase 3.  
 
We observed that H2O2 treatment induced an increase in lysosomal volume and such 
increase was prevented by specific caspase 3 inhibitor and molecular silencing of 
caspase 3. We discovered that Transcription Factor for EB (TFEB), the master gene 
for lysosome biogenesis, could be regulated by caspase 3. Inhibition of caspase 3 
inhibited the expression of TFEB as well as its nuclear localization, which is crucial 
for its transcriptional role in lysosome biogenesis. We therefore suggest a novel role 
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CHAPTER 1 INTRODUCTION 
1.1 Caspase 
1.1.1 The caspase family 
Caspases are aspartic acid-specific cysteine protease (Hence the name Caspase: 
Cysteine-Aspartate protease) belongs to the family of interleukin-1β-converting 
enzyme family. Caspases are synthesized as inactive proenzymes that are distributed 





In mammalian cells, fourteen caspases have been identified that can be divided into 
three major groups based on the homology in amino acid sequence and their function 
(Figure A). The inflammatory caspases (group I) and the initiator caspases (group II) 
are caspases with long prodomain. The inflammatory caspases (caspase 1, caspase 4, 
caspase 5, caspase 12, caspase 13 and caspase 14) play important role in cytokine 
maturation and inflammatory responses
2
. The initiator caspases are divided into those 
that contain either the Caspase-Recruitment Domain (CARD) (caspase 2 and 9)
3,4
, or 
those that contain the Death Effector Domain (DED) (caspase 8 and 10) at the N-
terminal
5,6
. The prodomain dictates how the caspases can be activated. DED and 
CARD are involved in autoactivation of initiator caspases by facilitating their 
recruitment into death- or inflammation- inducing signalling complexes
1
. Generally, 
caspase 8 and 10 with DED can be activated by cell surface receptors while the 
CARD-containing caspases, i.e. the initiator caspase 2 and 9, as well as the 
inflammatory caspases 1,4,5, 11 and 12 are activated by environmental insults.  The 
2 
 
third group of caspases with short prodomain is known as the effector or executioner 






Figure A. The caspase family. Three major groups of caspases. Group I: 
inflammatory caspases; group II: apoptosis initiator caspases; group III: apoptosis 
effector caspases. The CARD, the DED, and the large (p20) and small (p10) catalytic 







1.1.2 Mechanisms of caspases activation 
Caspases are synthesized as inactive zymogens known as procaspases and their 
activation is tightly controlled. The quaternary structure of an active caspase is 
composed of two large subunits and two small subunits from the procaspase, forming 
a tetrameric complex with two active sites (Figure B). The substrate cleavage site of 
caspases is highly conserved with a tetrapeptide motif with the stringent requirement 
of an aspartate residue in the P1 position. Caspases cleave their substrate on the 
carboxyl side of the aspartate residue. The residue at P4 position of the tetrapeptide 
motif determines the different substrate specificity of different caspases. The catalytic 
cysteine site consists of a pentapeptide motif (QACXG) and the catalytic reaction is 
carried out by the cysteine, histidine and glycine residues.   
 
 
Figure B. Scheme of procaspase activation. Cleavage of the procaspase requires 
sequential cleavage of the protease, which release the prodomain and the two catalytic 
subunits. Cleavage at the specific Asp-X bonds leads to the formation of the mature 
caspase, which comprises the heterotetramer p20 and p10. The residues involved in 






Activation of the effector caspases requires sequential proteolysis that separates the 
prodomain from the large subunit, and the large subunit from the small subunit. 
Subsequent heterodimerization of the subunits form the active caspase. The cleavage 
and activation of effector caspase are mediated by the initiator caspases or an 
activated effector caspase. The effector caspases act as effector of apoptosis through 
cleavage of cellular substrates that are responsible for biochemical or morphological 
changes during apoptosis. The activation of initiator caspases involves an assembly of 
other molecules that either aid in increasing the net concentration and/or induce a 
conformation change of the procaspase that facilitates their self-activation. Three 





, or induced conformation 
model
12
. As the name suggests, the initiator caspases are the initiator of a caspase 






1.1.3 Classical pathways of caspase 3 activation during apoptosis  
Apoptosis is a genetically regulated mechanism of programmed cell death 
characterized by cellular changes such as cell shrinkage, chromatin condensation, 
membrane blebbing, DNA fragmentation, as well as formation of apoptotic bodies 
which are phagocytised by adjacent cells and phagocytes
14
. It constitutes a common 
mechanism of cell replacement, tissue remodelling, and removal of damaged cells 
development, immune regulation and homeostasis of a multi-cellular organism
15
. The 
process of apoptosis can be initiated by a diverse range of intracellular or extracellular 
cell signals, such as ionizing radiation, chemotherapeutic agents, oxidative stress, 




A key feature of apoptosis is the activation of caspases. Inhibition of caspases can 
lead to induction of necrosis. Compared to necrosis, apoptosis is physiologically 
advantageous because cellular contents are packed into apoptotic bodies that are 
recognized and engulfed by phagocytosis, thereby preventing induction of 
inflammatory response and damage to surrounding tissues. As an executioner caspase, 
caspase 3 is the critical effector caspase for apoptosis. The human CASP3 gene, 
homologous to C. elegans CED-3 gene was first cloned from human Jurkat T-
lymphocytes in 1994
17
. Caspase-3 is either wholly or in part responsible for the 
proteolysis of a large number of substrates that contain a common Asp- Xaa-Xaa-Asp 
(DXXD) motif
18







, and protein kinases
23
. The cleavage of caspase 3 substrates are 
responsible for biochemical and morphological changes during apoptosis, such as cell 




, and nuclear 
condensation
25
. As the central player in the apoptotic machinery, caspase 3 activation 
6 
 









During apoptosis, caspase 3 is activated in the caspase cascade. The caspase cascade 
starts with the activation of the initiator caspases 8 and caspase 9 by pro-apoptotic 
signals. Once activated, caspase 8 and caspase 9 gain the ability to cleave and activate 
caspase 3. Generally, there are three pathways of caspase cascade activation during 
apoptosis: the death signal-induced, death receptor mediated pathway (also known as 
the extrinsic pathway), the stress-induced, mitochondria-mediate pathway (also 
known as the intrinsic pathway), and the less common granzyme pathway. Figure C 





Figure C. The intrinsic and extrinsic pathway of caspase 3 activation. The 
caspase cascade can be triggered through the extrinsic (death-receptor mediated) 
pathway or the intrinsic (mitochondrial) pathway. The intrinsic pathway is highly 
regulated by the Bcl-2 family of proteins. The released mitochondrial proteins 
Smac/DIABLO and HtrA2/Omi antagonize the inhibitors of apoptosis (IAPs). Cross-
talk exists between the two pathways through caspase 8-mediated cleavage of Bid, 





The extrinsic pathway is initiated by ligands binding to the apoptotic-inducing cell 
surface receptors known as the death receptors, which are the members of the tumour 
necrosis factor (TNF) receptor superfamily. The extrinsic pathway can be activated by 
multiple ligands binding to different death receptors, mediated by different adaptor 
molecules. However, the pathways to be activated are similar
29
. The homologous 
cytoplasmic sequence, the death domain (DD) of the death receptor allows the 
receptor to interact with the DED domain of caspase 8. Binding of ligands to the 
death receptor induces receptor trimerization, followed by adaptor molecule binding 
to the DD of the receptor.  The adaptor molecule works as a molecular scaffold that 
juxtaposes multiple procaspase 8 molecules, and together with the death receptors, 
form the death-inducing signalling complex (DISC).  Within DISC, the high local 
8 
 
concentration and favourable mutual orientation of multiple caspase 8 enable 
autoproteolytic activation of caspase 8. Activated caspase 8 then cleaves caspase 3 
and results in apoptosis.  
 
On the other hand, the intrinsic pathway of caspase cascade is activated by 
environmental insults that results in mitochondrial membrane permeabilization 
(MOMP), which enables cytosolic release of cytochrome c from the intermembrane 
space of mitochondria. In the cytosol, cytochrome c binds to the scaffolding protein, 
apoptotic protease activating factor-1 (Apaf-1).  The binding of cytochrome c to 
Apaf-1 induces ATP-dependent conformational change of Apaf-1. Subsequently, 
Apaf-1 recruits procaspase 9 by binding to the CARD of procaspase 9, leading to the 
formation of apoptosome complex. Interaction within the apoptosome complex results 
in conformational change of procaspase 9, which enhances the proteolytic activity of 
procaspase 9. Mature caspase 9 is released from the multimeric complex and activates 
caspase 3.  
 
The intrinsic pathway is highly regulated by the Bcl-2 family members. The Bcl-2 
family consists of anti-apoptotic proteins such as Bcl-2 and Bcl-XL, and pro-
apoptotic proteins such as Bax, Bad and Bid
30
. The Bcl proteins are involved in 
upstream of apoptosis in induction of caspase cascade. The interplay of these proteins 
in terms of localization, conformation and/or activity is crucial in regulating the 
mitochondrial event. Bcl-2 family plays important roles in cross talk of the two 
pathways. For example, caspase 8 may cleave Bid which then activates Bax, leading 






Lastly, in the granzyme pathway, caspase 3 is directly cleaved and activated by the 
serine protease granzyme B. The granzyme pathway is mediated by cytotoxic T cells 
and usually takes place in tumour cells or virus-infected cells. In this pathway, cells 
are first permeabilized by perforin, which allows granzyme B to be released from 
cytotoxic T cells into the target apoptotic cells. In the target cells, granzyme B 






1.1.4 Non-apoptotic functions of caspase 3 
In spite of their established role in apoptosis, caspases activation and substrate 
cleavage have been observed in the absence of cell death, suggesting alternative role 
of caspases beyond apoptosis. In recent years, mounting evidences have indicated that 
caspases also play important roles in a variety of non-apoptotic and apoptosis-like 
vital processes, including cell differentiation, cell signalling, and cellular remodelling. 
Remarkably, a significant portion of these studies are dedicated to the executioner 
caspase 3.   
 
Non-apoptotic roles of caspase 3 start to surface when scientists observe constitutive 
activation of caspase 3 in the absence of cellular stress and pro-apoptotic stimuli
32-34
. 
Moreover, proteolytic cleavage of known substrates of caspase 3, such as Poly (ADP-
ribose) polymerase (PARP), Lamin B, Spectrin and Acinus, can be detected during 
physiological event such as erythropoiesis and spermatid maturation
35-38
. These are 
well known substrates of caspase 3 during apoptosis. More importantly, caspase 3 
seems to be crucial in maintaining integrity of development. Caspase 3 knockout mice 
could survive to early perinatal life but with reduction in total skeletal muscle mass 
and are strikingly smaller compared to the wild-type mice
39
. Studies with caspase 
knockout mice also indicated that caspase 3 play important roles in  osteogenic 
differentiation of bone marrow stromal stem cells
40
 , neuronal differentiation of 
primary derived neuronal stem cells
41
 , and in proliferation and differentiation of adult 
hematopoietic stem cells
42
.   
 
Non-apoptotic roles of caspase 3 are well established in terminal differentiation that 
involves compartmentalized cellular degeneration resembling incomplete apoptosis. 
11 
 
During terminal differentiation, cells undergo drastic cellular architecture 
rearrangement, and these cells lost most of their organelles including mitochondria 
and nuclei. Nonetheless, cells remain metabolically active despite undergoing such 
apoptotic-like process. Although the process of terminal differentiation strongly 
resembles that of apoptosis, there are still distinct differences between terminal 
differentiation and apoptosis, and this may explain why the cells continue to survive. 
Whereas apoptotic cells usually exhibit membrane blebbing, there is no evidence of 
membrane blebbing or the formation of apoptotic bodies in differentiating lens fibre 
cells or erythroblasts
35
. Compared to apoptosis, the process of terminal differentiation 




 takes about 3 days 
to complete.  
 
On the other hand, caspase 3 can also execute its non-apoptotic role in different 
cellular frameworks that do not exhibit compartmentalized degeneration, by involving 
in other vital processes of non-degenerative nature. Many of these processes exhibit 
characteristics of apoptosis in terms of caspases activation and substrate cleavage. 
However, in many cases such as during differentiation, the timing and intensity of 
caspases-mediated signals may be critical in determining the cell fate of whether to 
differentiate or to die. 
 
To date, caspase 3’s non-apoptotic functions have been found in cellular 
differentiation, proliferation, immune functions, neuronal functions, as well as cell 
motility. Table 1 summarizes recent findings of caspase 3 involvement in non cell 




Table 1. Non-apoptotic functions of caspase 3 
Cellular function Cell type/model/processes Reference 
Differentiation  Erythroblast 
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 (including terminal Lens epithelial cells 
44
 
 differentiation) Platelets 
45
 
  Spermatid 
46
 
  Keratinocytes 
47
 
  Skeletal muscle 
48
 
  Neuronal stem cells 
41
 
  Bone marrow stromal stem cells 
40
 
  Hematopoietic stem cells 
42
 
  Embryonic stem cells 
49
 
  Macrophage 
50
 
  Glia 
51
 
Proliferation Forebrain cells  
52
 
  T cells 
53
 
  B cells 
54
 
Immune function Dendritic cell maturation 
55
 
  Interleukin (IL)-2 release 
56
 
  IL-16 processing 
57
 
Neuronal function Astrocyte cytoskeletal remodelling 
58
 
  Dendritic pruning 
59
 
  Synaptic plasticity 
60
 







1.1.5 Regulation of non-apoptotic functions of caspases 
The mechanisms to non-apoptotic roles of caspases are less well understood and 
remain to be fully investigated. It is suggested that the key to caspases’ non apoptotic 
roles could be their selective cleavage specific subsets of substrates, avoiding cell 
dismantling. For example, during erythroblast differentiation, caspase 3 cleaves 
GATA-1, a transcription factor specific to erythrocytes. On the other hand, caspase 3 
cleaves Mst-1, the transcription factor specific to muscle cells, during myoblast 
differentiation
48
. The importance of substrate specificity is further shown in 
proliferating B-cells where caspase 3 cleave p21 but not p27, although p21 and p27 




Transient and limited caspase activity 
In many circumstances, caspase activity might not be regulated in an all-or-nothing 
manner. There could be fine tune control of caspase activity, such that activation of 
caspase occurs for a limited period of time and its level is controlled within a certain 
threshold. This is supported by consistent observation of transient and limited caspase 
activity in cells where caspases execute their non-apoptotic function, such as 
differentiation of erythrocytes
61
, lens fibre cells
62




It is suggested that such controlled caspase activation regulates the substrate cleavage 
specificity of caspases for specific cellular function. Caspases have different affinities 
towards different substrates. Transient or low level of caspase activity favours the 
cleavage of the substrates that exhibit highest affinity
64
 . Interestingly, different level 
of caspase activity may change their cleavage pattern such that the substrates change 





example, RasGAP, a regulator of Ras- and Rho-dependent pathways, is differentially 
cleaved under different concentration of activated caspase 3. At low caspase 3 
activation, caspase 3 cleaves RasGAP to generate an N-terminal fragment with anti-
apoptotic properties. As the caspase activity increases, the fragment is further cleaved 
into two pro-apoptotic fragments that potentiate DNA damage-induced apoptosis in 
cells
67,68
. Similarly, the transcription factor STAT3 is reported to possess multiple 
caspase cleavage sites that are cleaved under different concentration of caspases. This 





On the other hand, it is suggested that some substrates are activated by low caspase 
activation but are inactivated by high caspase activation during apoptosis. One 
example is the transcription factor NF-kB, which is usually cleaved and inactivated by 
caspase 3 during apoptosis, and hence inactivates its survival pathway
70
. However, it 
is now known that during inflammatory response, NF-kB can also be activated by 
limited activation of caspase 3 through through a PARP-1–mediated mechanism in 





Several mechanisms have been accounted to achieve a transient and limited caspase 
activity, including post-translational modification of caspases and inhibition of 
caspase activity by anti-apoptotic proteins. Caspases activity can be altered by post-




. The inhibitor 
of apoptosis proteins (IAPs) are endogenous negative regulators of caspases activity 
by binding to activated caspase and inhibit their activities
75,76
. It is proposed that IAP 
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play important roles in controlling the extent of caspase activation; to not induce cell 
death but is sufficient to carry out its non-apoptotic function. In Drosophila, mutations 
in dbruce (Dropsophila IAP) result in spermatid individualization defects and male 
sterility
46
. Although caspase 3 is required for spermatid differentiation, excessive 
caspase activity could damage the spermatid nuclei, and this is prevented by dburce. 
Upon exposure to recorded birdsong, the brief caspase 3 activity found in the zebra 
finch auditory forebrain is proposed to play important role in memory and learning. In 
unstimulated forebrain, activated caspase 3 is present but bound to the endogenous 
inhibitor BIRC4 (XIAP), suggesting an IAP-regulated mechanism for rapid release of 




Compartmentalized activation of caspase 
During apoptosis, a global activation of caspase result in cleavage of many substrates, 
leading to cell dismantling and apoptosis. In contrast, compartmentalized caspase 
activation ensures that caspase process specific substrates in specific compartment. A 
classic example of spatial regulation of caspase activation leading to its specific roles 
is exemplified in megakaryocytes, where different caspase 3 distributions were found 
in cells destined for platelet formation and cells destined for cell death. Granular 
labelling of activated caspase 3 was detected in megakaryocytes during platelet 





Regulation at level of substrate cleavage 
Other than controlling the activation level and sequestration of activated caspase 3 
compartment, caspases can be post-translationally modified or bounded to adaptor 
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proteins to change their affinity towards specific subset of substrates
73,77
. Similarly, 
caspase substrates can also be modified to reduce/increase their affinity of cleavage 
by caspases. For example, phosphorylation of presenilin-2, a substrate of caspase 3 
during apoptosis, was found to protect it from caspase 3 cleavage
78
. On the other 
hand, the timing and intensity of substrate cleavage seems to be critical in 
determining the cell fate. For example, caspase 3 is reported to cleave Caspase-
Activated DNase (CAD) during in vitro skeletal muscle differentiation and in vivo 
regeneration, resulting in DNA strand breaks and damage
79,80
. Importantly, such 
cleavage of CAD by caspase 3 is also a common mechanism during apoptosis. 
However, it is found that the caspase 3-mediated DNA damage/strand breaks only 
occurs for a short period and occurs during early stages of the skeletal muscle 
differentiation
81
.  Therefore, whereas prolonged DNA damage/strand break results in 








1.2 Oxidative stress and caspase activation 
1.2.1 Oxidative stress 
Although the reactive oxygen species (ROS) play essential role in maintaining 
cellular homeostasis and vital function, their reactivity also causes potential biological 
damage, damage cellular lipids, proteins or DNA, inhibiting their normal function. 
Oxidative stress is a biochemical condition characterized by a pro-oxidant state of the 
cells, which is achieved by disruption in redox state and imbalance between ROS 
production and elimination
82
. However, in recent years it is also shown that 
physiological important redox signalling involves a temporary disturbance in the cell 
redox steady state
83
. Also, interventional trials have shown that shifting the balance 
by providing more antioxidants has limited protection effect during oxidative stress. 
This suggests that oxidative stress is not merely a global imbalance of oxidants and 
antioxidants. Hence, a new definition of oxidative stress as “a disruption of redox 
signalling and control” has been proposed83.  
 
In response to oxidative stress, the cells undergo a plethora of cell fate, including 
growth arrest, gene transcription, initiation of signal transduction pathways, and repair 
of ROS-induced DNA damage
84,85
 . The end result of oxidative stress could be cell 
death, apoptosis or necrosis, or cellular senescence, or cells could even continue to 
survive and proliferate
85
. Increased or sustained oxidative stress has also been 
observed in many pathological condition, such as in cancer, neurodegenerative 
diseases, chronic inflammatory processes, type II diabetes and in aging
86,87
. The 
differences in the outcome depend on the cellular genetic background, the species of 
ROS involved, and the intensity and duration of oxidative stress
88
. It has been 
reported that the effect of oxidative stress is dose-dependent: low level of ROS 
18 
 





In fact, low level or physiological level of ROS is implicated in signal transduction 
network known as redox signalling. This is attributed to the ability of low level of 
ROS to reversibly modify critical residues of macromolecules such as lipids, proteins 
and DNA. Such reversible modification of ROS is able to modulate the 
macromolecules’ activity and function in signal transduction. On the other hand, 
excessive ROS attacks macromolecules in an irreversible manner. Such unspecific 
attack of ROS often results in irreversible oxidative damage and succumb the cells to 




1.2.2 ROS-mediated caspase activation 
The link between oxidative stress/ ROS and caspase activation is well established on 







  have been shown to activate caspase cascade in different 
cell lines through mechanisms involving ROS. Also, exogenous addition of oxidants 
such as H2O2 has been shown to induce caspase activation and result in apoptosis
94
. It 
is believed that ROS are able to modulate caspase activity, through multiple 
mechanisms that could cross talk and may be dependent of each other. Generally, 
ROS mediates caspase activation through signalling pathway, while ROS inhibition of 
caspase activation occurs through direct modification of caspases molecules. 
Nevertheless, it has also been shown that ROS mediates caspase 9 activation by 
oxidatively modified caspase 9. This facilitates the interaction between caspase 9 and 
Apaf-1 through the formation of disulfide bond within a complex, essentially 
promoting apoptosome formation and caspase 9 activation
95
. On the other hand, it is 
postulated that caspase could be involved in ROS generation, as intracellular 
oxidation has been observed in cells undergoing apoptosis in response to non-
oxidative trigger.   
 
How ROS modulate caspases activation is intriguing. ROS are broad-spectrum 
molecules that have multiple targets and engage in multiple signalling pathways. It 
has been shown that ROS are able to modify both pro- and anti-apoptotic factors
96
. 
Hence, ROS signalling to caspase activation is likely to be complex and involves 
multiple pathways. Organelles prone to oxidative stress, such as the mitochondria, 
lysosome, and endoplasmic reticulum, are sensors to oxidative stress that further elicit 
series of complex pathways.  In addition, DNA damage and activation of the 
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Mitogen-activated protein kinase (MAPK) pathways are important response during 
ROS-induced apoptosis. Ultimately, most of these pathways converge on the 
mitochondrial pathway leading to caspase cascade activation. 
 
As the major site of intracellular ROS generation, mitochondria are particularly 
susceptible to the damaging effects of ROS. One of the consequences of ROS-induced 
mitochondria damage is mitochondrial outer membrane permeabilization (MOMP). 
Cytochrome c is release to facilitate apoptosome formation and caspase 9 activation, 
and consequently caspase 3 activation. MOMP is a point of no return for caspase 
activation and cell death. Activation of caspase cascade during oxidative stress 
through the mitochondrial pathway is supported by various experimental 
evidences
97,98
. Components within mitochondria sensitive to oxidative damage 
include the respiratory chain complexes
99,100





. Disruption or oxidation of these components may promote cytochrome 
c release and collapse of the mitochondrial transmembrane potential, and ultimately 
activation of the caspase cascade. 
 
Other than MOMP and cytochrome c release, ROS could trigger caspase cascade 
through modulation of components in the activating signalling complexes. For 
example, Apaf-1 has been found to be oxidized by ROS, which promotes apoptosome 






1.2.3 Caspase 3 activation during mild oxidative stress 
Despite the well-established pathways of caspase 3 activation by ROS leading to 
apoptosis, our lab has recently demonstrated that caspase 3 can be activated during 
mild oxidative without leading to cell death
104
. Mild oxidative stress elicited by 50µM 
H2O2 induced caspase 3 activation that was responsible for sustained repression of 
Sodium Hydrogen Exchanger-1 (NHE-1) protein expression, which has been 
implicated in cell proliferation and transformation
105
. Not only that the study was the 
first highlighting the role of caspases 3 in the oxidative repression of gene expression, 
it also revealed an alternative pathway of caspase 3 activation through iron-dependent 
mechanism in the absence of cell death. It is proposed that the decrease in NHE-1 
expression by activation of caspase 3 may be critical in arresting cell growth during 
mild oxidative stress, even in the absence of cell death.  
 
One of the characteristics of cancer cells is their ability to evade apoptosis, which 
results in uncontrolled proliferation. Surprisingly, in a number of viable cancer cells, 
constitutive caspases activities have been observed
32
. This implies that caspases have 
important roles in tumour progression other than their implication in apoptosis. 
Consistent with this observation, chronic oxidative stress or increased ROS level has 
been observed in many cancer cells
106,107
. Therefore, understanding the implications 
of caspase activation during mild oxidative stress may be important in shedding some 




1.3 Aim of study 
Caspase activation has been closely associated with apoptosis. In recent years, 
evidences that caspases are involved in a numbers of non-apoptotic processes have 
surfaced. For example, caspases are required in cellular function such as 
differentiation and proliferation of specific cell types. This means that caspases play 
important roles in the control of life and death. Nevertheless, how caspases are 
regulated as well as the pathway leading to their non-apoptotic roles is poorly 
understood.  
 
Previous study in our lab provided evidences that caspase 3 could have a non-
apoptotic roles in regulating gene expression during mild oxidative stress. When cells 
were treated with 50µM H2O2, NHE-1 gene expression was down-regulated. This 
down-regulation of NHE-1 gene was caspase 3 and 6 dependent
104
. Not only so, 
caspase 3 is also involved in ROS generation. Furthermore, although H2O2 treatment 
activated caspase 3 and 6, there was no apoptosis. 
   
The aim of our present study is to unravel the pathway leading to caspase 3 activation 
in the absence of cell death during mild oxidative stress. Also, the alternative role of 




CHAPTER 2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and reagents 
Company Chemical and reagents 
Hyclone, UT, USA 
Dulbecco’s modified Eagle’s medium (DMEM), 
Roswell Park Memorial Institute-1640 (RPMI-
1640) Foetal bovine serum (FBS), Phosphate 
Buffered Saline (PBS), Trypsin, L-glutamine 
Lonza (Walkersville, MD, 
USA) 
Gentamicin Sulphate 
Sigma-Aldrich, MO, USA 
Aprotinin, Pepstatin A, Phenylmethanesulfonyl 
Fluoride (PMSF), Leupeptin, Sodium Vanadate, 
Dimethylsulfoxide (DMSO), Deferoxamine 
mesylate salt (DFO), o-Phenantroline 
monohydrate (PHEN), Dithiothereitol (DTT), 
Staurosporine (STS), Dimethylthiourea (DMTU), 
Triton X-100, Propidium Iodide, RNAse A, 
Crystal Violet, Bovine Serum Albumin (BSA),  
Carbonyl cyanide m-chlorophenylhydrazone 
(CICCP), Pepstatin A, 4-(2-Aminoethyl) 
benzenesulfonyl fluoride hydrochloride (AEBSF) 
Acros Organics, Geel, 
Belgium 
Deferiprone (DFP) 
Merck KGaA, Darmstadt, 
Germany 
Methanol, Hydrogen peroxide, Sodium Dodecyl 
Sulphate (SDS) 
R&D system 
zDEVD-FMK, zIETD-FMK, z-LEHD,FMK, 
zVAD-FMK, zFA-FMK,QVD-OPH 
Enzo Life Sciences 
Ac-DEVD-AFC, Ac-IETD-AFC, Ac-LEHD-AFC, 
Pifithrin-α (PFT) 
Cell Signaling Technology 
(Beverly, MA, USA) 
Chaps cell extract buffer 
BD Pharmingen, USA Cell lysis buffer (1X) 
Molecular Probes (Molecular 
Probes Inc., Eugene, OR, 
USA) 
5-(and-6)-chloromethyl 2',7'-
dichlorodihydrofluorescein diacetate acetyl ester 
(CM-H2DCFDA),4-Amino-5-Methylamino-2',7'-
Difluorofluorescein Diacetate (DAF-FM 
Diacetate), Hoechst 34580, Lysotracker® DND-
99, Acridine Orange, 3, 3’-
Dihexyloxacarbocyanine Iodide (DIOC6(3)) 
Pierce Biotechnology, 
Rockford, IL, USA 
Coomassie Plus
TM
 Protein assay reagent, 
Restore
TM
 Western Blot Stripping buffer, 
Supersignal West Pico chemiluminescent substrate 
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Calbiochem (Merck KGaA, 
Darmstadt, Germany) 
5,10,15,20-Tetrakis(4-
sulfonatophenyl)porphyrinato Iron (III), Chloride 
(FeTPPS), zFY-CHO, Cathepsin G inhibitor I 
Invitrogen, CA, USA 
Opti-MEM®I reduced serum medium, 
Lipofectamine
TM
 RNAiMAX   






Cell Signaling Technology  Rabbit polyclonal anti-caspase 3 (#9662) 
(Beverly, MA, USA) Rabbit monoclonal anti-cleaved caspase 3 (#9664) 
  Rabbit monoclonal anti-caspase 8 (#4790) 
  Mouse monoclonal anti-caspase 9 (#9508) 
  Mouse monoclonal anti-p53 (#2524) 
  




Polyclonal Goat Anti-Rabbit 
Immunogluobulins/HRP (P0448) 
Pierce (Pierce, Thermo Fisher 
Scientific Inc, Rockford, IL, 
USA) 
Horseradish peroxidase (HRP)-conjugated goat 
anti-mouse secondary antibody (#31430) 
Sigma-Aldrich (St Louis, 
USA) 
Mouse monoclonal Anti-β-actin (A5441) 
Abcam (Cambridge,  Rabbit polyclonal anti-cathepsin B (ab33538) 
UK) Mouse polyclonal anti-cathepsin L (ab6314) 
  Rabbit polyclonal anti-active caspase 3 (ab13847) 
  Rabbit polyclonal anti-p21 (ab7960) 
  
Rabbit polyclonal anti-Lamin B1 (ab16048) 
 
Santa Cruz  Rabbit polyclonal anti-SOD1 (sc-11407) 
Biotechnology, CA,  Rabbit polyclonal anti-TFEB (sc-48784) 
USA Rabbit polyclonal anti-HO-1 (sc-10789) 
Molecular Probes (Molecular 









2.1.3 Cell lines and cultures 
L6 rat myoblasts stably transfected with full length proximal 1.1kb of NHE-1 
promoter were obtained from Dr. Larry Fliegel (Department of Biochemistry, 
University of Alberta, Canada)
108. L6 myoblasts were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% FBS, 2mM L-glutamine, 
0.25mg/ml Geneticin (G418 sulfate), and 1mM Gentamicin Sulfate at 37ºC, with 5% 
CO2 in a humidified atmosphere. For experiment with serum starved condition, cells 
were grown in DMEM with 0.5% FBS.    
 
2.2 Methods 
2.2.1 Treatment of cells with H2O2 and other compounds 
A stock solution of 10mM H2O2 was prepared by diluting 30% (v/v) H2O2 solution 
with 1X PBS. Diluted H2O2 in 1X PBS was added into the medium to attain the final 
concentration required in the experiments.  Stock solutions of caspase peptide 
inhibitors (zVAD-FMK, zDEVD-FMK, QVD-OPH, zIETD-FMK, zLEHD-FMK), 
DFO, zFA-FMK, zFY-CHO, cathepsin G inhibitor I, pepstatin A, and calpeptin were 
dissolved in DMSO. Stock solutions of DFP, DMTU, cPTIO, AEBSF, and FeTPPS 
were dissolved in 1XPBS. For treatment of cells with compounds with DMSO, a 
vehicle control (DMSO) was included in the experimental setup.  
 
2.2.2 Morphology studies 
The morphology of the cells was analyzed by under Nikon Eclipse TS100. 




2.2.3 Luciferase Gene Reporter Assay 
NHE-1 promoter activity of stably transfected cells were assessed with single-
luciferase assay (Promega, Madison, WI) according to manufacturer’s instructions. 
Adherent cells were lysed with 100µl reporter lysis buffer at room temperature and 
lysate harvested were incubated on ice for 10min. For single luciferase assay, 10µl 
cell lysate was added to 50µl luciferase substrate. Bioluminescence generated was 
measured using a Sirius luminometer (Berthold, Pforzheim, Germany). Luminescence 
readings obtained were normalized to protein concentration of the lysate, which was 
measured using the Coomassie Plus
TM
 Protein assay reagent.  
 
2.2.4 Caspase Activity Assay 
After treatment, cells were harvested and were lysed with 1X Cell Lysis Buffer 
(10mM Tris-HCl at pH 7.5, 10mM NaH2PO4/NaHPO4, 130mM NaCl, 1% Triton X-
100, 10mM sodium pyrophosphate) (BD Biosciences Pharmingen, San Diego, CA). 
After centrifugation at 12,000rpm, 4ºC for 5 min, 40µl cell lysate was added to 44µl 
of reaction mixture consists of: 4µl of specific caspase substrate (1mM (stock conc), 
caspase 8 substrate: Ac-LETD-AFC, caspase 3 substrate: Ac-DEVD-AFC and 
caspase 9 substrate: Ac-LEHD-AFC) and 40µl of 2X Reaction Buffer  (10mM 
HEPES, pH 7.4, 2mM EDTA, 6mM DTT, 10mM KCl and 1.5mM MgCl2) 
supplemented with protease inhibitors (1mM phenylmethylsulfonyl fluoride (PMSF), 
10μg/ml aprotinin, 10μg/ml pepstatin A, 20μg/ml leupeptin), into a 96-well 
microplate. Samples were incubated at 37ºC for 1h and fluorescence was read at an 
excitation wavelength of 400 nm and an emission wavelength of 505 nm using 
Spectrofluoro Plus spectroflurometer (TECAN, GmbH, Grodig, Austria). Caspase 
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activity was normalized against protein concentration of each sample and expressed 
as relative fluorescence unit per microgram of protein (RFU/µg).  
 
2.2.5 Cell viability estimation by Crystal Violet Assay 
Crystal violet assay was used to estimate the number of viable and adherent cells. 
Cells were grown on 6-well plates and were subjected to various treatments. After 
washing with 1X PBS, cells were stained with 0.5ml crystal violet solution (0.75% 
(w/v) crystal violet, 50% (v/v) ethanol, 1.75% (v/v) formaldehyde, 0.25% (w/v) 
NaCl) for 10min. Excess crystal violet solution was carefully washed away with water 
and the plates were left to air-dry. Each well was then added with 1ml of 1%SDS/PBS 
to solubilize the dye retained in the adherent cells. 50µl of cell lysate from each well 
was transferred into separate wells of 96-well microplate and the absorbance was 
measured at 595nm using Spectrafluor Plus spectrofluorometer (TECAN, GmbH, 
Grödig, Austria). Cell density at each time point (with or without treatments) was 
expressed as the percentage relative to the density of control untreated cells at time 
zero.  
 
2.2.6 DNA Fragmentation Assay/Cell cycle analysis 
Cells harvested were centrifuged at 2500rpm for 5min. Cell pellet were washed twice 
with 1XPBS and were resuspended in ice-cold PBS/1%FBS. Cells were then fixed 
with 70% ethanol and were left at 4°C for at least 30min. After fixation, cells were 
centrifuged at 10,000rpm for 5min at 4ºC. The cell pellet was washed twice with ice-
cold 1% FBS/PBS before staining with 500μl of PI/RNaseA staining solution for 
30min at 37ºC. The samples were then subjected for flow cytometry analysis using the 
excitation wavelength of 488nm and emission wavelength of 610nm on the flow 
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cytometer (BD FACSCanto II, BD Biosciences, CA, USA). Flow cytometry data was 
analyzed with Cyflogic
TM
 software (CyFlo Ltd, Finland). 
 
2.2.7 SDS-PAGE and Immunoblotting 
Cells harvested were lysed with Chaps cell extract buffer (Cell Signalling Technology 
(Beverly, MA, USA)) supplemented with 1mM PMSF and 5mM DTT. Before 
measurement of protein concentration, the lysate was centrifuged at 14,000rpm for 
10min to remove the debris. Protein quantification was performed using the 
Coomassie Plus™ Protein assay reagent (PIERCE, Thermo Fisher Scientific Inc, 
Rockford, IL, USA).  
 
For detection of protein of interest, 50µg of total protein per sample was subjected to 
SDS-PAGE with 15% (v/v) acrylamide resolving gel at 110V using the Bio-Rad 
Mini-PROTEAN 3 Cell (CA, USA). Protein samples were mixed with the 5x loading 
dye (0.313M Tris HCl (pH 6.8), 10% SDS (w/v), 0.05% bromophenol blue, 50% 
glycerol and 0.5M DTT) and heated at 95°C for 5min before loading. Kaleidoscope 
pre-stained standards (Bio-Rad, CA, USA) was used to estimate the molecular sizes 
of the proteins bands obtained. The resolved proteins were transferred onto a 
nitrocellulose membrane by the wet transfer method at 350mA for 1h using the Bio-
Rad Mini Trans-Blot Electrophoretic Transfer Cell (CA, USA) in an ice-bath. 
Blocking was done in 5% fat-free milk in Tris-buffered saline /Tween 20 (TBST) (20 
mM Tris-HCl, pH 7.6, 137mM NaCl, 0.1% Tween 20), at room temperature for 1h. 
The membrane was washed with TBST to remove excess milk before incubated with 
primary antibodies (diluted in 5% (w/v) BSA) overnight at 4°C. After washing off the 
unbound primary antibody with TBST, the membrane was subsequently incubated with 
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the respective horse radish peroxidase conjugated secondary antibodies (diluted in 5% 
(w/v) milk) for 1h at room temperature. Probed protein of interest was detected with 
enhanced chemiluminscence using SuperSignal Chemiluminescent Substrate 
(PIERCE, IL, USA) with Kodak Biomax MR X-ray film. For re-probing of the same 
membrane for different proteins, membrane was stripped with Restore Western Blot 
Stripping Buffer for 10min at 37ºC, before incubation with primary and secondary 
antibody for another protein. For densitometric analysis, the bands obtained were 
scanned with EPSON Perfection 1250 and analyzed by FujiFilm Multigauge V3.0. 
The band density for proteins was normalized against the band density of β-actin. 
 
2.2.8 RNA Interference (RNAi) Assay 
Cellular transfection of siRNA was performed using Lipofectamine® RNAiMAX 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. Cells 
were seeded and grown for at least 24h before transfection. For transfection, medium 
was replaced with DMEM/10% FBS without antibiotics. siRNA of specific gene or 
control siRNA was mixed with the Lipofectamine®  RNAiMAX in Opti-MEM®I 
reduced serum medium (Invitrogen, Carlsbad, CA, USA). The mixture was incubated 
for 20min. resuspended thoroughly, and was subsequently added drop-wise into each 
well. At 8h post-transfection, cells were washed with 1XPBS and replaced with fresh 
DMEM/10%FBS medium. Cells were harvested for various assays at 24h or 48h post-
transfection.  
 
siRNA for caspase 3 (ON-TARGETplus SMARTpool - Rat CASP3), p53 (ON-
TARGETplus SMARTpool - Rat TP53), and cathepsin B (ON-TARGETplus 
SMARTpool - Rat CTSB) were purchased from Dharmacon (Thermo Scientific, IL, 
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USA). A negative control siRNA (QIAGEN, Valencia, CA, USA) that is non-
homologous to any known gene sequence was used as a negative control.  
 
2.2.9 Nuclear-Cytoplasmic Fractionation 
Nuclear-cytoplasmic fractionation was performed with the NE-PER Nuclear and 
Cytoplasmic Extraction Reagents (PIERCE, Thermo Fisher Scientific Inc, Rockford, 
USA) according to manufacturer’s protocol. Briefly, cells harvested were centrifuged 
at 2200rpm, 5min at 4ºC. Pellet collected was resuspended in 200µl of ice-cold CERI 
buffer by vortexing at maximum speed for 15s. 11µl CERII buffer was added and the 
resuspension was vortexed for 5s before centrifugation at 16,000g for 5min at 4ºC. 
The supernatant was collected as the cytosolic fraction. The nuclear pellet was lysed 
in 100µl of ice-cold NER buffer. The resuspension was vortexed for 15s and 
subsequently incubated on ice for 20min. Debris was removed by centrifugation at 
16,000g for 10min at 4ºC and the supernatant was collected as the nuclear extract.  
 
2.2.10 Immunofluorescence Assay using Confocal Microscopy 
For immunofluorescence assay, cells were seeded on cover slips on 12-well plate. 
Cells were fixed with 4% paraformaldehyde for 30min at room temperature. After 
fixation, cells were washed with 1XPBS twice to remove excess paraformaldehyde. 
After washing with 100mM NH4Cl for 5min twice and washing with 1XPBS, cells 
were permeabilized with 0.2% TX-100 (Sigma-Aldrich, LO, USA) for 10min at room 
temperature. Cells were then incubated with primary antibody of the protein of 
interest for 2h at room temperature. After washing with PBS, cells were incubated 
with Rhodamine Red
TM
-X goat anti-rabbit IgG R6394 (Molecular Probes Inc., 
Eugene, OR, USA) and with Hoechst 34580 (Molecular Probes Inc., Eugene, OR, 
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USA) for 1h. The cells were washed three times with 1XPBS before the cover slip 
was mounted for confocal analysis using Olympus FluoView1000 (FV1000; 
Olympus, Japan) with identical acquisition parameters for the same image session. 
Pictures are analyzed with Olympus FLUOVIEW Ver1.7a Viewer. 
 
2.2.11 Intracellular ROS/RNS Measurement by flow cytometry 
Cells were trypsinized and were centrifuged at 2500 rpm for 5min to collect the cell 
pellet. Cell pellet was resuspended and incubated with 5µM CM-H2DCFDA (for ROS 
measurement) or DAF-FM Diacetate (for RNS measurement) at 37ºC in dark. After 
15min, cell suspension was centrifuged at 2500rpm for 5min and washed with PBS 
twice to remove excess dye. Cells were resuspended in 500µl PBS and were subjected 
to flow cytometry analysis of DCF or DAF fluorescence using the FITC channel on 
the flow cytometer (BD FACSCanto II, BD Biosciences, CA, USA). Flow cytometry 
data was analyzed with Cyflogic
TM
 software (CyFlo Ltd, Finland). 
 
2.2.12 Analysis of lysosomal membrane permeabilization with the Acridine 
Orange assay 
Cells were incubated with a solution of 10µM Acridine Orange (Molecular Probes 
Inc., Eugene, OR, USA) for 30min at 37ºC before treatment with H2O2. At various 
time points, cells were trypsinized and were centrifuged at 2500 rpm for 5min to 
collect the cell pellet. Cells were resuspended in 500µl PBS and were subjected to 
flow cytometry analysis of Acridine Orange fluorescence using the FITC-A channel 




2.2.13 Analysis of lysosomal volume with Lysotracker and Acridine orange 
staining 
Lysosomal volume was assessed by immunofluorescence with Lysotracker® Red 
DND-99 (Molecular Probes Inc., Eugene, OR, USA) or by flow cytometry with 
Lysotracker DND99 or Acridine Orange staining. For immunofluorescence, cells 
were seeded on cover slips on 12-well plate. After treatments with H2O2 or drugs, 
cells were incubated with a solution containing 75nM Lysotracker® Red DND-99for 
45min, 37ºC. Cells were then fixed with 4% paraformaldehyde for 30min at room 
temperature. After fixation, cells were washed with 1X PBS twice to remove excess 
paraformaldehyde. After washing with PBS, the cover slip was mounted for confocal 
analysis using Olympus FluoView1000 (FV1000; Olympus, Japan) confocal 
microscope with identical acquisition parameters for the same image session. For 
flow cytometry analysis of lysosomal volume, cells were exposed to a solution of 
75nM Lysotracker® Red DND-99 for 45min or 10µM Acridine Orange for 30min 
after treatment with H2O2. Cells were then trypsinized and were centrifuged at 2500 
rpm for 5min to collect the cell pellet. Cells were resuspended in 500µl 1X PBS and 
were subjected to flow cytometry analysis of Lysotracker or Acridine Orange 
fluorescence under the PerCP-A channel (BD FACSCanto II, BD Biosciences, CA, 
USA). Flow cytometry data was analyzed with Cyflogic
TM
 software (CyFlo Ltd, 
Finland). 
 
2.2.14 Analysis of Mitochondrial Outer Membrane Permeabilization with 
DIOC6(3) 
Cells were trypsinized and were centrifuged at 2500 rpm for 5min to collect the cell 
pellet. Cell pellet was resuspended and incubated with 10nM DIOC6(3) (Molecular 
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Probes Inc., Eugene, OR, USA) at 37ºC in dark. After 15min, cell suspension was 
centrifuged at 2500rpm for 5min and washed with PBS twice to remove excess dye. 
Cells were resuspended in 500µl PBS and were subjected to flow cytometry analysis 
using the FITC-A channel on the flow cytometer (BD FACSCanto II, BD Biosciences, 
CA, USA). Flow cytometry data was analyzed with Cyflogic
TM
 software (CyFlo Ltd, 
Finland). 
 
2.2.15 Statistical Analysis 
Data are presented as mean ± standard error of mean (S.E.M.) where n≥3. Student’s t-
test was performed when appropriate, using the Microsoft Excel software, with p-
value of less than 0.05 considered significant. In the event of n=2, data are presented 




CHAPTER 3 RESULTS 
3.1 Characterization of non-classical caspase 3 activation upon H2O2 
treatment 
3.1.1 Exposure of L6 myoblasts to non-toxic does of H2O2 results in caspase 3 
activation 
Exogenous addition of H2O2 to cells may result in a physiological or pathological 
outcome, depending on the H2O2 concentration. At low dosage, H2O2 acts as second 
messenger in cell signalling, its mechanism includes oxidation of redox-sensitive 
cysteine residues of protein kinases and transcription factors
109
. At high dose, H2O2 
can cause apoptosis and necrosis
110
. In the present study, we aimed to establish a 
setting whereby H2O2 elicits a mild oxidative stress without inducing cell death.  
 
L6 myoblasts were seeded in DMEM containing 10% FBS overnight before exposure 
to 50μM H2O2. After 1 hour, cells were recovered in fresh 10% FBS medium (Figure 
1A). To show that 50μM H2O2 does not induce cell death, we used the well-
established apoptotic inducer, staurosporine (STS) as a positive control for apoptosis. 
STS was discovered in 1977 in a culture of an actinomycete (Streptomyces strain AM-
2282(T))
111
, and was first shown to be a potent inhibitor of protein kinases
112,113
. STS 
was shown to induce apoptosis in a variety of cell lines and has since been used as an 
apoptotic trigger. STS induces apoptosis through multiple signalling pathways, 













To determine if the cells undergo apoptosis after H2O2 treatment, we assessed 
morphological and biochemical hallmarks of apoptosis, including observation of cell 
morphology, inspection of nuclear fragmentation, and determination of the percentage 
of cells in subG1 phase by cell cycle profiling. L6 myoblasts exposed to 1μM STS 
showed shrunken and rounded cell morphology at 24h and 48h, while cells exposed to 
50μM H2O2 maintained a normal morphology that was comparable to the control 
untreated cells (Figure 1B).  Staining of cell nuclei with the Hoechst 34580 nucleic 
acid stain enables observation of cell nuclei under the fluorescence microscope. The 
nuclei of L6 myoblasts remained intact when cells were exposed to 50μM H2O2 for 
24h and 48h while nuclei condensation and nuclear fragmentation were observed in 
STS-treated cells (Figure 1C).  
 
The degree of nuclei fragmentation was quantitatively measured by use of a DNA 
intercalating dye, Propidium Iodide (PI), in Fluorescence-absorbent cell scanner 
(FACS) analysis of cell cycle (Figure 1D). In apoptotic cells where DNA are 
fragmented, a high population of cells show reduced DNA content, as fragmented 
DNA leaks out of the cells when cells are permeabilized. This is shown as the subG1 
phase on cell cycle profile. In this phase, the DNA content is lower than that in the G1 
phase (n). Therefore, the subG1 phase of cell cycle profile corresponds to the 
population of apoptotic cells with fragmented DNA. At 24h and 48h, the basal level 
of apoptotic cells was 2-4% of the whole population. Upon treatment with H2O2, there 
was a slight increase of 2% in the percentage of subG1 cells; however, the increase 
was statistically insignificant (Figure 1D). In contrast, STS-treated samples recorded 
an increase of close to 7 fold in percentage of cells in the subG1 phase compared to 
control cells. The percentage of apoptotic cells upon STS treatment was 14.6% and 
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20.7% at 24h and 48h respectively (Figure 1D). This indicated that a significant 
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Figure 1. Effect of H2O2 and STS on cellular morphology and survival.  
(A) Basic experimental setup of the project: exposure of L6 myoblasts to 50µM H2O2.  
L6 myoblasts were treated with 50μM H2O2 and 1μM STS for 24 and 48 hours. (B) 
Cell morphology was observed under a phase contrast microscope. (C) Cell nuclei 
were stained with Hoechst 34580 nucleic acid stain and nuclear morphology was 
observed under a confocal microscope. c: nuclear condensation; f: nuclear 
fragmentation. (D) Cells were stained with the propidium iodide (PI) dye for cell 
cycle profile analysis. Percentage of cells in subG1 phase was tabulated as percentage 
of apoptotic cells. The data represent the means of three independent experiment ± 
S.E.M., *P < 0.05. Pictures shown are representative of at least 3 independent 
experiments.  
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Although H2O2 treatment had no effect on cellular morphology, we observed a 
decrease in cell density in both H2O2 and STS-treated culture plates. In STS-treated 
culture plate, there was a significant population of cells floating in the medium, 
indicating that cells were undergoing a certain degree of anoikis, i.e. cell death due to 
loss of attachment (Figure 1B). In comparison, most cells remained attached to the 
culture plate even after treatment with H2O2, suggesting that H2O2 treatment did not 
induce apoptosis or anoikis, but a retarded cell growth (Figure 1B). A quantitative 
measurement of cell growth was achieved by crystal violet staining of adherent cells 
(Figure 2). While control untreated cells showed an exponential growth pattern, H2O2-
treated cells showed no increase in cell number, suggesting an arrested cell 
proliferation up to 72 hours (Figure 2A). Figure 2B showed the representative cell 
cycle profile for H2O2- and STS-treated cells. The cell cycle profile of H2O2-treated 
cells was comparable to the control untreated cells at 24h and 48h and no obvious cell 
cycle arrest was observed. When the numbers in each cell cycle phase were tabulated 
and represented as numbered graph, we found that there was no relative increase in 
G1, S or G2/M phase for H2O2-treated cells (Figure 2C, D and E). This suggests that 
H2O2-induced cell growth arrest was not due to cell cycle arrest. In contrast, STS-
treated cells had a decreased population in the G1 phase at 24h and 48h, and increased 
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Figure 2. H2O2 treatment resulted in decreased cell growth without inducing cell 
cycle arrest. (A) Cells were treated with 50μM H2O2 for indicated time points and 
were stained with crystal violet to quantify adherent cell density. The data are the 
means of four independent experiments ± S.E.M., *P < 0.05.  
(B) Cell cycle profile analysis of cells treated with 50µM H2O2 or 1µM STS for 24 or 
48 hours. Graphs shown are representative of four independent experiments.  
The percentage of cells in (C) G1, (D) S, and (E) G2/M phase from FACS analysis of 
cell cycle was tabulated. The data are the means of four independent experiments ± 
































Lastly, we assessed the occurrence of Mitochondrial Outer Membrane 
Permeabilization (MOMP) upon treatment of H2O2 and STS. MOMP is a crucial step 
in the intrinsic pathway of apoptosis and is generally considered as a “point of no 
return” to cell death. It leads to cytosolic release of pro-apoptotic proteins, driving the 
activation of caspase cascade through apoptosome formation. After MOMP, activated 
caspase 3 cleaves the p75 subunit of mitochondrial respiratory chain complex I, 
producing ROS and discrupting the mitochondrial membrane potential
122
. Hence, 
MOMP is characterized by loss of mitochondrial membrane integrity and a drop in 
mitochondrial membrane potential. The fall in mitochondrial membrane potential can 
be measured by use of a cationic lipophilic dye, DIOC6(3).The accumulation of 
DIOC6(3) in the mitochondria matrix is driven by the mitochondrial membrane 
potential
123
. Disruption to the mitochondrial membrane integrity and mitochondrial 
membrane potential results in decreased uptake of DIOC6(3) to the mitochondria. 
Hence, the occurrence of MOMP is evident by a decrease in DIOC6(3) staining. To 
artificially induce MOMP, we used an oxidative phosphorylation uncoupler, CICCP. 
Figure 3 showed that both STS and CICCP treatment resulted in 10-15% decrease in 
the DIOC6(3) fluorescence intensity. In contrast, there was no change to the 
fluorescence intensity after H2O2 treatment. This indicates that mitochondrial 











Figure 3. STS treatment, but not H2O2, induced Mitochondrial Outer Membrane 
Permeabilization. Cells were treated with 50μM H2O2, 1μM STS or 20μM CICCP 
for 4 hours before they were stained with 10nM DIOC6(3) dye. Green mitochondrial 
fluorescence of 10,000 cells per sample was determined by flow cytometry using the 
FITC-A channel. The data are the means of four independent experiments ± S.E.M., 






































































We proceeded to analyze caspase 3 activation by H2O2 by measurement of caspase 3 
activity with a fluorogenic substrate Ac-DEVD-AFC, and Western Blot analysis of 
caspase 3 cleavage. Both H2O2 and STS treatment resulted in time-dependent caspase 
3 activation when measured using Ac-DEVD-AFC (Figure 4). For H2O2-treated cells, 
the increase of caspase 3 activity was first detected at 8h, increasing by 2 fold as 
compared to the control. Caspase 3 activity continued to increase and peaked at 24h 
with about 5 fold increase compared to the control (Figure 4A). Compared to H2O2, 
STS-induced caspase 3 activity started earlier at 6h, gradually increased and peaked at 
12h with about 30 fold increase compared to the control (Figure 4A). Using Western 
Blot analysis, cleavage of caspase 3 was evident by the detection of a 17kda band on 
the Western Blot, which represents the p17 fragment of activated caspase 3. H2O2-
induced caspase 3 cleavage was detected at 9h, which then gradually increased and 
peaked at 18-24 hours post-treatment (Figure 4B). This is similar to its caspase 3 
activity profile observed using Ac-DEVD-AFC. For STS-treated cells, cleavage of 
caspase 3 were detected as early as 3-4h, which then gradually increased and peaked 
at 12-18 hours post-treatment (Figure 4B). Again, this is similar to its caspase 3 








Figure 4. H2O2 and STS treatment resulted in time-dependent caspase 3 
activation. (A) Caspase 3 activity in cells exposed to 50μM H2O2 or 1μM STS for 
indicated time points, measured with the fluorogenic substrate Ac-DEVD-AFC. The 
data are the means of three independent experiments ± S.E.M., *P < 0.05, compared 
to control at respective time points. 
(B) Western Blot analysis of caspase 3 cleavage in cells exposed to 50μM H2O2 or 
1μM STS for indicated time points. Western Blots shown are representative of three 
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3.1.2 Localization of activated caspase 3 upon H2O2 treatment 
Having established that H2O2 treatment induced caspase 3 activation in a non-cell 
death condition, we next assessed the localization of cleaved (activated) caspase 3. 
Cells were incubated with a primary antibody purchased from Abcam (ab13847), 
which is specific to the cleaved fragment activated caspase 3, p17 and p12. 
Subsequently, cells were incubated with a secondary antibody conjugated to 
Rhodamine. Immunofluorescence study showed a striking difference between STS 
and H2O2-treated cells in terms of cleaved caspase 3 localization (Figure 5A). At 12h, 
staining of activated caspase 3 in red was observed mainly in the nuclei of STS-
treated cells. At 24h post treatment, such staining was observable in both H2O2- and 
STS-treated cells, but in different cellular compartment. For H2O2-treated cells, 
cleaved caspase 3 accumulated mainly in the nuclei, whereas for STS-treated cells, 
cleaved caspase 3 accumulated mainly in the cytoplasm. At 48h, intensity of cleaved 
caspase 3 staining decreased in H2O2-treated cells but nevertheless remained in the 
nuclei. For STS-treated cells, cleaved caspase 3 remained in the cytoplasm (Figure 
5A). 
 
To validate the specificity of the staining, we co-incubated the cells with the primary 
antibody ab13847 and its corresponding blocking peptide. Nuclear staining of cleaved 
caspase 3 upon H2O2 treatment was completely blocked by co-incubation with the 
blocking peptide, suggesting that the staining was specific and associated with not 
background staining (Figure 5B). We then performed an immunofluorescence study 
with two different primary antibody purchased from different company, ab13847 and 
cell signalling #9664. Incubation with either antibody in H2O2-treated cells revealed a 
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red nuclear staining (Figure 5C). Such findings confirmed the localization of activated 





Hoechst Cleaved Caspase 3
Hoechst + 





Hoechst Cleaved Caspase 3
Hoechst + 













Hoechst Cleaved Caspase 3
Hoechst + 










( with blocking peptide)
Hoechst + 







Figure 5. Sub-cellular localization of cleaved caspase 3 after H2O2 and STS 
treatment. (A) L6 myoblast were treated with 50μM H2O2 or 1μM STS for 12, 24 or 
48 hours. After fixation, cells were incubated with primary antibody specific to the 
p17 fragment and p12 fragment of activated (cleaved) caspase 3 (Abcam ab13847), 
followed by confocal microscopy analysis. Immunofluorescence images shown are 
representative of three independent experiments. Negative control refers to samples 
incubated in blocking buffer without primary antibody. (TI: Transmitted Light Image) 
(B) Cells were treated with 50μM H2O2 for 24 hours. After fixation, cells were 
incubated with Abcam ab13847 and the antibody-specific blocking peptide, followed 
by confocal microscopy analysis. (C) Cells were treated with 50μM H2O2 for 24 
hours. After fixation, cells were stained with two different primary antibodies, Abcam 
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3.1.3 H2O2-induced caspase 3 activation was initiator caspase-independent 
Because of their proteolytic nature, caspases are synthesized as inactive zymogens 
that are activated in a highly regulated proteolytic cascade. Activation of caspases 
involves proteolytic cleavage of themselves or each other, depending on their position 
in the proteolytic hierarchy. Classical apoptosis scenario involves self activation of 
initiator caspases, usually caspase 8 or 9, and activation of the executioner caspases 
by the activated initiator caspases. L6 myoblasts were treated with H2O2 or STS for 
different time points and were harvested for caspase activity assay and Western Blot 
analysis of caspase 8 and 9 cleavage. STS as the classical apoptosis inducer activated 
both caspase 8 and 9 (Figure 6A, B and C). In contrast, initiator caspase 8 and 9 were 
not activated upon H2O2 treatment (Fig 6A, B and D). This finding was intriguing as 
initiator caspases are generally activated prior to executioner caspase so as to mediate 
the cleavage of executioner caspases. The absence of caspase 8 and 9 activation in 
H2O2 system led us to deduce that H2O2-induced caspase 3 activation was caspase-
independent. To confirm, L6 myoblasts were pre-incubated with specific peptide 
inhibitors of caspase 8, zIETD-FMK, or caspase 9, zLEHD-FMK, before treatment 
with H2O2 and STS. These peptide inhibitors specifically and irreversibly inhibit its 
corresponding caspases through a covalent thioether adduct with the cysteine of the 
active site. Pre-incubation with zLEHD-FMK was able to decrease cleavage of 
caspase 3 by STS treatment (Figure 7A). In contrast, both z-IETD-FMK and zLEHD-
FMK had no effect on H2O2-induced caspase 3 cleavage (Figure 7B). Moreover, 
control experiment showed that the dose of zIETD-FMK and zLEHD-FMK used were 
sufficient to inhibit caspase 8 and 9 activity induced by STS treatment (Figure 7C and 
D). Such findings suggest that H2O2-mediated caspase 3 cleavage was independent of 
the initiator caspases.  Interestingly, upon STS treatment, we could not detect the 
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usual p18 and p10 cleaved fragment of caspase 8. Instead, a 30kda band was detected 
on Western Blot, suggesting that an alternative cleavage pattern of caspase 8 by STS 
treatment in L6 myoblasts. Such alternative cleavage pathway has been found 
recently and was described in details by Hoffmann et al.
124





























































































Figure 6. STS treatment, but not H2O2 treatment, activated the initiator caspases 
8 and 9.  (A) Caspase 8 activity in cells exposed to 50μM H2O2 or 1μM STS for 
indicated time points, measured with the fluoregenic substrate Ac-IETD-AFC. The 
data are the means of four independent experiments ± S.E.M., *P < 0.05. (B) Caspase 
9 activity in cells exposed to 50μM H2O2 or 1μM STS for indicated time points, 
measured with the fluoregenic substrate Ac-LEHD-AFC. The data are the means of 
three independent experiments ± S.E.M., *P < 0.05, as compared to control at 
respective time points. (C) Cells were treated with 1μM STS for indicated time points 
and were harvested for Western Blot analysis of caspase 8 and 9 cleavage. Western 
Blot shown is representative of three independent experiments. (D) Cells were treated 
with 50μM H2O2 for indicated time points and were harvested for Western Blot 
analysis of caspase 8 and 9 cleavage. STS-treated lysate was included as a positive 
control. Western Blot shown is representative of three independent experiments.  
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Figure 7. Caspase 3 activation upon H2O2 treatment was not prevented by 
inhibition of the initiator caspases 8 and 9.  (A) Cell were pre-treated with 30μM of 
specific caspase inhibitors, z-IETD-FMK (caspase 8) or z-LEHD-FMK (caspase 9), 
for 2 hours before exposure to 1μM STS.  After 5 hours, cells were harvested and 
subjected to Western Blot analysis. Western Blot shown is representative of three 
independent experiments.  (B) Cell were pre-treated with 30μM of specific caspase 
inhibitors, z-IETD-FMK (caspase 8) or z-LEHD-FMK (caspase 9), for 2 hours before 
exposure to 50μM H2O2.  After 24 hours, cells were harvested and were subjected to 
Western Blot analysis of caspase 3 cleavage. Western Blot shown is representative of 
three independent experiments.  (C) Caspase 8 activity in cells treated with 1μM STS 
for 24 hours, with or without z-IETD-FMK pre-treatment. (D) Caspase 9 activity in 





































Next, L6 myoblasts were pre-incubated with the pan-caspase inhibitors zVAD-FMK 
for 2 hours before exposure to 50µM H2O2 or 1µM STS (Figure 8). Cleavage of 
caspase 3 by STS treatment was decreased in the presence of 25µM and 50µM 
zVAD-FMK (Figure 8A). In contrast, pre-incubation with the same dose of zVAD-
FMK did not inhibit caspase 3 cleavage by H2O2 treatment (Figure 8B). Again, 
control experiment showed that 25µM zVAD-FMK was sufficient to inhibit caspase 
3, 8 and 9 activity induced by STS (Figure 8C, D and E). Also, although zVAD-FMK 
was unable to decrease H2O2-induced caspase 3 processing, it could block caspase 3 
activity completely (Figure 8F). This suggests that zVAD-FMK could direct inhibit 
the activated caspase 3 while not affecting its processing from the pro-enzyme. Based 
on these results, we concluded that H2O2-mediated caspase 3 cleavage could be 
independent of another caspase. Although both STS and H2O2 treatment led to 
caspase 3 activation, such caspase 3 activation differed in terms of magnitude, time of 
activation, as well as their upstream mechanisms. A summary of H2O2- and STS-







































































































































































Figure 8. Caspase 3 activation upon H2O2 treatment is caspase-independent.  L6 
myoblasts were pre-treated with increasing doses of the pan-caspase inhibitor, zVAD-
fmk, for 2 hours before exposure to (A) 1μM STS or (B) 50μM H2O2.  After 24 hours, 
cells were harvested and subjected to Western Blot analysis of caspase 3 cleavage. 
Western Blots shown are representative of two independent experiments.  
Cells were pre-treated with 25μM zVAD-FMK before exposure to 1μM STS. After 
24 hours, cells were harvested for (C) caspase 3, (D) caspase 8, and (E) caspase 9 
activity assay. 
(F) Cells were pre-treated with 25μM zVAD-FMK before exposure to 50μM H2O2.  








































Table 2. Summary of H2O2- and STS- induced caspase 3 activation. (* time of 
activation, 
#






 ~ 8h ~ 3h 
Caspase 3 activation Magnitude 
#
 ~ 4-7X ~ 25-30X 
Caspase 8 activation no yes 
Caspase 9 activation no yes 
     Effect of caspase 8/9 inhibitor on caspase 3 
activation 
no yes 
       Effect of pan caspase inhibitor on caspase 3 
activation 
no yes 
MOMP no yes 






3.2 Mechanism of H2O2-induced caspase 3 activation 
3.2.1 H2O2-induced caspase 3 activation is dependent on lysosomal cathepsins 
B and L  
3.2.1A A non-caspase cysteine protease is responsible for H2O2-induced caspase 3 
activation 
In section 3.1, we have shown that H2O2-induced caspase 3 activation was 
independent on the conventional caspase proteolysis cascade. This suggests an 
alternative path to caspase 3 activation without the involvement of the initiator 
caspases 8 and 9 (Figure 9). As caspase 3 is synthesized as an inactive proenzyme, its 
full activation requires proteolytic cleavage of the protein into functional fragments 
(p17 and p12), which then oligomerize to form the active enzyme. Therefore, a 






Figure 9. An unconventional path to caspase 3 activation upon H2O2 treatment. 
Upon H2O2 treatment, caspase 3 was activated. Activated caspase 3 was translocated 
into the nucleus. The activation of caspase 3 occurred in absence of MOMP and was 
independent of the initiator caspases 8 and 9. The protease upstream of caspase 3 is 
yet to be determined. 
 
 
There are 3 major families of proteases, serine, aspartate, and cysteine proteases. 
Besides the well-established caspase activation in a caspase cascade, other protease-
mediated caspase 3 activation has been reported in the literature. It has been shown 
that caspase activation and apoptosis was inhibited by serine protease and aspartatic 
inhibitor, especially when caspase activation and apoptosis were not affected by pan 
caspase inhibitors. Several reports have highlighted the importance of serine proteases 
during DNA damage-induced apoptosis. It has been shown that in PC12 cells, the 
serine protease inhibitors, AEBSF (also known as Pefabloc) and N-tosyl-l-













yet to be determined
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DNA damage-induced neuronal cell death, by preventing mitochondrial event such as 
cytochrome c release or loss of transmembrane potential
125
.  Another study has shown 
that AEBSF could block caspase activation, PARP degradation and apoptosis in 
melanoma cell lines, IGRmyc-3 and IGR39D, neuroblastoma cell line IMR32, as well 
as a rat-derived fibroblast. While such effect of AEBSF was observed in DNA 
damage-induced apoptosis by etoposide and irradiation, its protective effect was not 
extended to TNF-α-induced apoptosis126. Besides DNA damage-induced apoptosis, 
serine inhibitors APF, TLCK, and AEBSF were also reported to inhibit caspase 




On the other hand, the aspartate inhibitor Pepstatin A has been shown in several 
studies to inhibit caspase activation and apoptosis. For example, in human foreskin 
fibroblast, Pepstatin A prevented cytochrome c release and caspase activation and 
thereby delaying staurosporine-induced cell death
120
. It was also shown that, in both 
naive, and Nerve Growth Factor-treated, PC12 cells, Pepstatin A provided a 
protective effect from cell death caused by oxygen and glucose deprivation when used 
alone or in combinations with zVAD-FMK
128
. In contrast, pre-incubation with 




To investigate the involvement of serine proteases and aspartate proteases in H2O2-
induced caspase 3 activation, we pre-incubated the cells with the broad-spectrum 
serine protease inhibitor, AEBSF or the aspartate inhibitor Pepstatin A before 
treatment with 50µM H2O2. Pre-incubation with up to 200µM, of AEBSF did not 
decrease caspase 3 activity (Figure 10). We did not increase the dose of AEBSF as a 
higher dose would stress the cells and resulted in cell death. Similarly, pre-incubation 
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of cells with Pepstatin A, did not inhibit caspase 3 activity (Figure 11), suggesting 





Figure 10. Caspase 3 activation upon H2O2 treatment was independent of serine 
protease. Cells were pre-treated with 50, 100 or 200μM of a broad-spectrum serine 
protease inhibitor, AEBSF, for 2 hours before exposure to 50μM H2O2.  After 24 
hours, cells were harvested for caspase 3 activity assay analysis. The data are the 














































Figure 11. Caspase 3 activation upon H2O2 treatment was independent of 
aspartate protease. Cells were pre-treated with 50 or 100μM of a broad-spectrum 
aspartate protease inhibitor, Pepstatin A, for 2 hours before exposure to 50μM H2O2.  
After 24 hours, cells were harvested for caspase 3 activity assay analysis. The data are 
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In Figure 8B, we showed that up to 50µM, zVAD-FMK was unable to prevent 
caspase 3 cleavage by H2O2 treatment. However, 50µM zVAD-FMK was sufficient to 
inhibit caspase 3 cleavage induced by STS treatment, despite the fact that STS-
induced caspase 3 cleavage was much higher than that induced by the H2O2 treatment 
(Figure 8A). When we pre-incubated the cells with 100µM of zVAD-FMK, H2O2-
induced caspase 3 cleavage was prevented (Figure 12).  The difference between the 
effect of 50 µM and 100µM zVAD-FMK could be explained by the unspecific 
inhibitory effect of zVAD-FMK at high dose. It has been well documented that 
zVAD-FMK cross-inhibits other proteases, such as calpains and cathepsins, 
particularly at the typical doses used for caspase inhibition (100 μM)129,130. In fact, it 
was believed that, at such a high dose, zVAD-FMK functioned as a broad-spectrum 




Figure 12. Caspase 3 cleavage upon H2O2 treatment was decreased by 100μM 
zVAD-FMK.  L6 myoblasts were pre-treated with 25, 50 or 100μM pan-caspase 
inhibitor, zVAD-fmk, for 2 hours before exposure to 50μM H2O2.  After 24 hours, 
cells were harvested and subjected to Western Blot analysis of caspase 3 cleavage. 
























3.2.1B Inhibition of cathepsin B and L prevented caspase 3 activation by H2O2 
treatment 
The cysteine protease family consists of three major groups: caspases, cathepsins 
(part of its family) and calpains. While the roles of caspases in apoptosis are well 





The calcium-activated cysteine protease, calpain, plays an important role in ER stress-
mediated apoptotic pathway. The involvement of calpain in apoptosis is supported by 
attenuation of apoptosis through pharmacological inhibition of calpain
132
. Calpain can 
be a negative regulator as well as a positive regulator of caspase 3 activation. It has 
been shown that calpain could cleave procaspase 7, 8 and 9 leading to their 
inactivation
133
. On the other hand, calpain could cleave Bid to its pro-apoptotic 
truncated form, resulting in MOMP and caspase cascade activation
134,135
. To 
determine if calpain is the upstream activator of caspase 3 in our system, we pre-
incubated the cells with Calpeptin, a cell permeable calpain inhibitor before treatment 
with H2O2 (Figure 13). We found that caspase 3 activation was unaffected in the 




Figure 13. Caspase 3 activation upon H2O2 treatment was independent of 
calpain. L6 myoblasts were pre-treated with 10 or 20μM of calpain inhibitor, 
Calpeptin, for 2 hours before exposure to 50μM H2O2.  After 24 hours, cells were 
harvested for caspase 3 activity assay analysis. The data are the means of three 









































The involvement of cathepsins in cell death has been well reported, as discussed in 
Section 1. Also, in vitro cleavage of caspases by cathepsins has also been 
reported
136,137
. To test if the H2O2-induced caspase 3 activation is dependent on 
cathepsin, we pre-incubated the cells with zFA-FMK, an inhibitor specific to 
cathepsin B and L, before treatment with 50µM H2O2. Pre-incubation with zFA-FMK 
inhibited both caspase 3 activity and cleavage in a dose-dependent manner (Figure 
14).  Similarly, pre-incubation of cells with inhibitor specific to cathepsin L, zFY-
CHO inhibited caspase 3 activity and cleavage dose-dependently at 50µM and 100µM 
(Figure 15). Inhibiton of caspase 3 activation by zFA-FMK was more efficient than 
zFY-CHO, suggesting that both cathepsin B and L played a role in caspase 3 
activation. Furthermore, silencing of cathepsin B resulted in a decrease in caspase 3 
activation in H2O2-treated cells, thereby confirming that cathepsin B was involved in 
H2O2-mediated caspase 3 activation (Figure 16). It was also noted that silencing of 
cathepsin B in untreated cells activated caspase 3 (Figure 16B). Despite the caspase 3 
activation, silencing of cathepsin B was not affecting  cell survival, and the reason 
and possible outcome of this mild caspase 3 activation is yet to be investigated  
(Figure 16C). As zFA-FMK and zFY-CHO could inhibit both caspase 3 activity and 
cleavage, this indicates that the inhibitors were acting upstream of caspase 3, instead 








Figure 14. Caspase 3 activation upon H2O2 treatment was inhibited by zFA-
FMK. Cells were pre-treated with 25, 50 or 100μM zFA-FMK for 2 hours before 
exposure to 50μM H2O2. After 24 hours, cells were harvested for (A) caspase 3 
activity assay and (B) Western Blot analysis. The data are the means of three 
independent experiments ± S.E.M., *P < 0.05. Western blot shown is representative 
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Figure 15. Caspase 3 activation upon H2O2 treatment was inhibited by zFY-
CHO. Cells were pre-treated with 25, 50 or 100μM zFY-CHO for 2 hours before 
exposure to 50μM H2O2. After 24 hours, cells were harvested for (A) caspase 3 
activity assay and (B) Western Blot analysis. The data are the means of three 
independent experiments ± S.E.M., *P < 0.05. Western blot shown is representative 
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Figure 16. Knock-down of Cathepsin B decreased caspase 3 activation by H2O2 
treatment.  Cell were transiently transfected with siRNA specific to cathepsin B 
(siCatB) or negative control siRNA (siCo). Cells were treated with 50μM H2O2 24h 
post-transfection. At 24h post-H2O2 treatment, cells were harvested for (A) caspase 3 
activity assay and (B) Western Blot analysis. (C) Cell morphology after silencing of 
cathepsin B was observed under a phase contrast microscope. The data are the means 
of three independent experiments ± S.E.M., *P < 0.05.  Western blot indicating 
knock-down efficiency of cathepsin B is representative of four independent 

















































To eliminate the possibility that the inhibitors used (zFA-FMK or zFY-CHO) might 
cross-inhibit caspase 3 activity, the inhibitors’ effect on the enzymatic activity of 
activated caspase 3 were tested. zFA-FMK or zFY-CHO were added to STS-treated 
cell lysates, which contained fully activated caspase 3, on a 96-well plate. The 
mixture of inhibitors and lysate were then added to enzymatic reaction containing the 
fluorogenic substrate of caspase 3, Ac-DEVD-AFC, and measured for caspase 3 
activity. There was no inhibition of caspase 3 activity with addition of zFA-FMK or 
zFY-CHO, up to 100µM (Figure 17). In contrast, caspase 3 activity was completely 
abrogated with 25µM of the pan-caspase inhibitor, zVAD-FMK (Figure 17). The 
results indicate that both zFA-FMK and zFY-CHO did not have a direct inhibitory 






Figure 17. In vitro caspase activity assay with zFA-FMK and zFY-CHO.  Cells 
were treated with 1μM STS and were harvested after 24 hours. Cell lysate was added 
with increasing dose of zVAD-FMK, zFA-FMK or zFY-CHO. Caspase 3 activity in 








































































To determine whether the inhibitory effects of zFA-FMK or zFY-CHO were 
restricted to H2O2 treatment, we serum starved the cells for 24 hours. We found that 
serum starvation resulted in caspase 3 activation at a similar level to that induced by 
H2O2 treatment (Figure 18). Although caspase 3 was activated, these treatments did 
not lead to cell death, as evident by the observation of cell morphology and nuclei 
staining. Upon serum starvation, cellular morphology characteristic of apoptotic cells, 
such as cell shrinkage was not detected (Figure 19A). Similarly, cell nuclei remained 
intact with minimal signs of nuclei condensation and fragmentation sighted (Figure 
19B). zFA-FMK or zFY-CHO was added to serum starved cells and results showed 
that serum starvation-induced caspase 3 activity could be effectively blocked by zFA-
FMK or zFY-CHO (Figure 20). This confirmed that the involvement of cathepsin B 




Figure 18. Serum starvation induced caspase 3 activation. Cell were treated 50µM 
H2O2 for 24 hours, or serum-starved overnight. Cells were harvested for caspase 3 
activity assay. The data are the means of three independent experiments ± S.E.M., *P 












































Figure 19. Effect of serum starvation on cellular morphology. Cells were serum-
starved for 24 or 48 hours. (A) Cell morphology was observed under a phase contrast 
microscope. (B) Cell nuclei were stained with Hoechst stain and nuclear morphology 
was observed under a confocal microscope. Pictures shown are representative of at 














Figure 20. Inhibition of Cathepsin B and L decreased serum starvation-induced 
caspase 3 activation. Cells were serum starved overnight and were treated with 
50μM of zFA-FMK or zFY-CHO. Cells were harvested for caspase 3 activity assay 


















































3.2.1C Cathepsin B was translocated into the cytoplasm upon H2O2 treatment 
Having established the involvement of cathepsin B and L in H2O2-mediated caspase 3 
activation, we next examined their protein expression. Cells were treated with H2O2 at 
different time points and were harvested for cathepsin B and L Western Blot analysis. 
Western Blot of cathepsin B detected three bands, which corresponds to the 
procathepsin B (40kda), the mature cathepsin B in single-chain form (30kda), and the 
heavy chain of the double-chain form (25kda) (Figure 21A). The double-chain form is 
the proteolytic product of the mature single-chain form. Both double-chain and 
single-chain forms of cathepsin B are considered as the mature cathepsin B with fully 
activated enzymatic properties. Densitometric analysis of Cathepsin B protein 
expression revealed a steady increase in the protein level of the single-chain form of 
mature cathepsin B at 24h and 48h (Figure 21B). The protein level of the heavy-chain 
form and procathepsin B remained unchanged until 24h post-H2O2 treatment. At 48h 
post-H2O2 treatment, there was an increase in the protein level of both heavy chain 
and procathepsin B (Figure 21C and D). For cathepsin L, a single band at 25kda as 
the mature cathepsin L was detected (Figure 22A). Densitometric analysis showed 














3h           5h           9h          12h         24h        48h
























































































Figure 21. Expression of cathepsin B protein upon H2O2 treatment. (A) Cells 
were treated with 50μM H2O2 for indicated time points and were harvested for 
Western Blot analysis of cathepsin B protein expression level.  Densitometric analysis 
of (B) single chain, or (C) double chain, heavy form or mature cathepsin B, 
expression, normalized to loading control β-actin. The change in mature cathepsin B 
protein expression was shown as a fold difference relative to control cells at 
respective time points. The data are the means of five independent experiments ± 
S.E.M., *P < 0.05.  
(C) Densitometric analysis of procathepsin B expression, normalized to loading 
control β-actin. The change in procathepsin B protein expression was shown as a fold 
difference relative to control cells at respective time points. The data are the means of 







































Figure 22. Expression of cathepsin L protein upon H2O2 treatment. (A) Cells 
were treated with 50μM H2O2 for indicated time points and were harvested for 
Western Blot analysis of mature cathepsin L protein expression level. (B) 
Densitometric analysis of mature cathepsin L expression, normalized to loading 
control β-actin. The change in mature cathepsin L protein expression was shown as a 
fold difference relative to control cells at respective time points. The data are the 
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Both cathepsin B and L are lysosomal proteases while caspase 3 is a cytosolic protein. 
Cytoplasmic relocalization of cathepsins is therefore necessary for the proteolytic 
action to take place. Cathepsin B localization was assessed by immunofluorescence. 
Cells treated with 50µM H2O2 were incubated with a primary antibody specific to 
cathepsin B and were observed under the confocal microscope. Figure 23A showed 
the typical staining of lysosomes with LysoTracker® Red DND-99. Figure 23B 
showed that, in control untreated cells the red staining of cathepsin B was typical of 
the staining of lysosomes, as shown in Figure 23A. However, in H2O2-treated cells, it 
showed a diffused cytoplasmic staining, indicating that cathepsin B has translocated 








Figure 23. Cathepsin B translocated from the lysosomes into the cytoplasm upon 
H2O2 treatment. (A) L6 myoblasts were incubated with a diluted LysoTracker® Red 
DND-99 solution (75nM) for 45min, 37°C, followed by observation under a confocal 
microscope. (B) L6 myoblasts were treated with 50μM H2O2 for 24 hours. After 
fixation, cells were incubated with primary antibody specific to cathepsin B, followed 
by observation under a confocal microscope. Nuclei were stained blue with Hoechst 









Next, we investigate the occurrence of lysosomal membrane permeabilization (LMP) 
as cathepsins release is always associated with LMP, or vice versa. LMP was 
quantified by Acridine Orange staining. Figure 24 showed a simple illustration of the 
working mechanism of Acridine Orange. The lysosomotropic probe Acridine Orange 
is a metachromatic fluorophore that accumulates in acidic organelles and displays a 
red to orange fluorescence when excited by blue light. On lysosomal rupture, the dye 
is released into the cytosol where its fluorescence spectrum changes from red to 
green. Therefore, a decrease in red fluorescence or an increase in green fluorescence 




Figure 24. Graphical illustration of the working mechanism of Acridine Orange 










To measure LMP in our system, cells were pre-stained with Acridine Orange for 
30min prior to H2O2 treatment. Time kinetic study of FACS analysis of Acridine 
Orange cytosolic green fluorescence revealed an increase of 8% and 14% in the 
fluorescence intensity at 2h and 4h respectively (Figure 25). This indicates that LMP 
has taken place at 2-4h post-H2O2 treatment. Such increase in green fluorescence 
gradually subsided after 4h and the fluorescence intensity was decreased to basal level 
at 18h. After 24h, a decrease in green fluorescence was observed and at 48h, the 
decrease was about 17% from the control (Figure 25).  
 
 
Figure 25. H2O2 treatment resulted in lysosomal membrane permeabilization at 
2-4h. Cells were exposed to an Acridine Orange solution (10μM) for 30 min at 37°C, 
before cells were treated with 50μM H2O2 for indicated time points. Green cytosolic 
fluorescence of 10,000 cells per sample was determined by flow cytometry using the 
FITC-A channel. The data are the means of four independent experiments ± S.E.M., 
































































3.2.2 H2O2-induced caspase 3 activation was redox-regulated 
We have established a pathway of cathepsin-mediated caspase 3 activation via LMP 
in the absence of cell death. Still, the question remains as how a transient dose of 
H2O2 could result in the generation of such signalling pathway. The time gap between 
the earliest event of LMP detected (2h) and H2O2 treatment (0h) suggests the 





Figure 26. An upstream reaction led to cathepsin-dependent caspase 3 activation. 
H2O2 treatment triggered LMP at 2-4h. The occurrence of LMP resulted in cathepsin 
B and L release, which cleaved and activated caspase 3 at 8-48h. An upstream 
pathway(s) was postulated to be mediating H2O2 effect at 0-2h leading to LMP. (pC3: 
















When exogenously added H2O2 diffuse across the membrane bilayer, it is expected to 
cause a disturbance to the intracellular redox balance. Depending on the dose of H2O2, 
such disturbance could be reversed by the cellular antioxidant system, or it could be 
irreversible. Again, the irreversible effect of H2O2 on redox balance could have 
diverse effects on the cells, depending on the amount of H2O2. Such effects could be 
the generation of a signalling pathway, induction of oxidative stress, and/or cell death. 
 
In our system, 50µM H2O2 induced an oxidative stress to the cells as evident by the 
up-regulation of Heme Oxygenase 1 (HO-1) protein (Figure 27). HO-1 is a stress-
responsive protein induced by a variety of oxidative challenges
138,139
  and therefore 
can be used as a marker for oxidative stress. Both 50 and 150µM H2O2 treatment 
caused an up-regulation of the HO-1 protein at 4 and 24 hours-post treatment (Figure 
27A). Such up-regulation was not observed in STS-treated cells. It was observed that 
upon 50µM H2O2 treatment, the up-regulation of HO-1 protein expression was 
sustained up to 48 hours (Figure 27B). This also indicates that 50µM H2O2 treatment 








Figure 27. Up-regulation of HO-1 upon H2O2 treatment. (A) L6 myoblasts were 
treated with 50 or 150µM H2O2, or 1µM STS for 4 and 24 hours. Cells were 
harvested for Western Blot analysis of Heme Oxygenase 1 (HO-1) expression. (B) 
Cells were treated with 50µM H2O2 for indicated time points and were harvested for 
Western Blot analysis of HO-1 expression. Western Blots are representative of two 
independent experiments.   
 
 
The up-regulation of HO-1 protein expression is associated with change in cellular 
redox state. We hypothesized that the upstream reaction before LMP could be redox-
regulated. Due to its chemical structure, H2O2 has mild oxidation property. Most of 
the physiological and pathological actions of H2O2 are mediated through its more 
reactive by-products of oxygen species. Both iron and ROS are known mediators of 
LMP
140
, however it should be noted that iron is also an essential mediator of H2O2 
reaction. In this section, we investigate the possible involvement of iron and a second 
ROS/RNS in the activation of caspase 3. 
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3.2.2A Iron chelation prevented H2O2-induced caspase 3 activation 
When the cells were pre-incubated with an iron chelator, Deferiprone (DFP), the up-
regulation of HO-1 was partially inhibited, but not completely (Figure 28). This 
indicates that oxidative stress induced by H2O2 treatment was partially mediated 
through a reaction with iron. This suggests that iron was an important factor in ROS 
generation through reaction with H2O2. However, it is not known if it was also 
significant in its role in iron-mediated caspase 3 activation. We hypothesized the 
following involvement of iron in caspase 3 activation: 1) iron was required in a 
catalyzed reaction (e.g. Fenton’s reaction) to generate a reactive H2O2 by- product 
which carries out the subsequent reaction, 2) iron was required in the upstream 




Figure 28. Iron chelation decreased H2O2-induced HO-1 up-regulation. Cells 
were pre-treated with 20μM iron chelator Deferiprone (DFP) for 2 hours before 
exposure to 50μM H2O2. Cells were harvested at indicated time points for Western 
Blot analysis of HO-1.   
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To evaluate the importance of iron in caspase 3 activation, cells were pre-incubated 
with either of the two iron chelators, Deferoxamine (DFO) or DFP as measured for 
caspase 3 activity and cleavage. Upon iron chelation, H2O2-induced caspase 3 activity 
and caspase 3 cleavage was almost completely abrogated (Figure 29). In contrast, iron 
chelation had no effect on STS-induced caspase 3 activation. Compared to DFO, DFP 
is more soluble and enters the cells readily and efficiently to reach the major 
intracellular sites of iron accumulation. Entry of DFO into the cells is much slower 
and requires more incubation time to reach significant concentration in the cell
141
. 
Since the cell oxidative response was detected as early as 1h after addition of H2O2, 
DFO was unsuitable as the iron chelator in our system to measure the effect of iron as 
an upstream species in caspase 3 activity. LMP was therefore measured using DFP as 
the iron chelator. LMP was completely inhibited when cells were pre-incubated with 
DFP (Figure 30). 
 
Subsequently, DFP was added to cells at various time points before or after exposure 
to H2O2. Results showed that only with addition of DFP at 0h, meaning a co-existence 
of H2O2 and DFP, caspase 3 activity and cleavage was completely inhibited, whereas 








Figure 29. Iron chelation prevented caspase 3 activation. L6 myoblasts were pre-
treated with iron chelators, Deferoxamine (DFO, 20µM) or Deferiprone (DFP, 
50µM), for 2 hours before exposure to 50μM H2O2 or 1μM STS.  After 24 hours, cells 
were harvested for (A) caspase 3 activity assay and (B) Western Blot analysis of 
caspase 3 cleavage. The data are the means of three independent experiments ± 








































- - +       - - +       - - +    


















Figure 30. LMP was inhibited by iron chelation. (A) L6 myoblasts were exposed to 
10μM Acridine Orange and 50μM DFP for 30 min at 37°C, before treatment with 
50μM H2O2 for 4 hours. Green cytosolic fluorescence of 10,000 cells per sample was 
determined by flow cytometry using the FITC-A channel. The data are the means of 
three independent experiments ± S.E.M., *P < 0.05. (B) A representative flow 































































Figure 31. Iron chelation at the first hour of reaction inhibited caspase 3 
activation.  L6 myoblasts were exposed to 50μM H2O2 and were co- or post-treated 
with DFP at different time points. At 24h post-H2O2 treatment, cells were harvested 
for (A) caspase 3 activity assay and (B) Western Blot analysis. The data are the means 
of three independent experiments ± S.E.M., *P < 0.05. Western blot shown is 
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The uptake of H2O2 into the cells is a time-dependent process. Given that the culture 
medium contains iron, one may argue that the reaction of H2O2 with iron could 
happen intracellular or extracellular. The culture medium used in experiments, 
DMEM contains Ferric Nitrate (Fe(NO3)3•9H2O) with the concentration of 0.1mg/L 
or 0.25µM. However, it is unlikely that the H2O2-iron reaction took place in the 
medium. Firstly, the low concentration of iron in the medium means that it is unlikely 
to be the rate-limiting factor for the reaction to take place. Secondly, ferric iron is the 
stable oxidative state of iron that does not react with another oxidation agent, such as 
H2O2. Therefore, we hypothesized that the iron content in the medium did not take 
part in H2O2-mediated signalling.  
 
To test the hypothesis, cells were treated with H2O2 in RPMI-1640 and were 
harvested at indicated time points. The RPMI-1640 is an iron-free medium, thereby 
preventing any chance of H2O2 reacting with extracellular iron before entering the 
cells. Result shows that, at 24h post-H2O2 treatment, there was no difference in the 
morphology of cells treated in DMEM or RPMI (Figure 32A). There was also no 
difference in caspase 3 activation between cells treated with H2O2 in DMEM or 
RPMI. H2O2 treatment in cells cultured in DMEM or RPMI resulted in a caspase 3 
activation of 5.4 fold (Figure 32B). Cells were then treated with H2O2 in RPMI and 
harvested at different time points. Result shows that upon H2O2 treatment, caspase 3 
was activated in a time-dependent manner. The maximum activation was registered at 
24h post H2O2 treatment (Figure 32C). These result supported our hypothesis that 
extracellular iron in the medium was not involved in the H2O2-mediated signalling. 



















































Figure 32. Extracellular iron was not required in caspase 3 activation by H2O2 
treatment. Cells were treated with 50μM H2O2 in DMEM or RPMI for 24 hours. (A) 
Cell morphology was observed under a phase contrast microscope. Pictures shown are 
representative of three independent experiments. (B) Cells were harvested for caspase 
3 activity assay. The data are the means of three independent experiments ± S.E.M. 
(C) Cells were treated with 50μM H2O2 in RPMI for indicated time points, and were 
harvested for caspase 3 activity assay analysis. The data are the means of three 








































3.2.2B Peroxynitrite and nitric oxide were involved in caspase 3 activation by H2O2 
Having established the involvement of intracellular iron in H2O2-mediated caspase 3 
activation, we next investigate the involvement of ROS/ reactive nitrogen species 
(RNS) in caspase 3 activation. Two widely used fluorophore, CM-H2DCFDA (or in 
short, DCF) and DAF-FM Diacetate (or in short, DAF) were used to detect any 
increase in ROS or RNS after H2O2 treatment. Both DCF and DAF are redox sensitive 
dye that fluoresces when oxidized by intracellular ROS or RNS. The increase in DCF 
and DAF fluorescence was measured by FACS analysis and the fluorescence intensity 
correlates to the ROS or RNS level in cells.    
 
At 0.5 to 1 hour after H2O2 treatment, an increase in DCF fluorescence was detected, 
but the increase was statistically insignificant (Figure 33A). Subsequently, there was 
an overall increase in the DCF fluorescence starting from 2h to 48h post-H2O2 
treatment (Figure 33B). Such increase in DCF staining ranged from 130-160% 
relative to the control. Figure 33C shows an alternate graphical representation of DCF 




















































































Figure 33. ROS measurement upon H2O2 treatment using the CM-H2DCFDA 
probe. Cells were treated with 50μM H2O2 for (A) 0.5h and 1h or (B) 2h, 4h, 6h, 8h, 
12h, 24h and 48h, and were incubated with CM-H2DCFDA for 20min, 37°C. Green 
cytosolic fluorescence of 10,000 cells per sample was determined by flow cytometry 
using the FITC-A channel. The data are the means of five independent experiments ± 
S.E.M., *P < 0.05, as compared to control at respective time points.  



































A time kinetic study of DAF staining revealed an overall increase in nitric oxide level 
after H2O2 treatment. As with DCF staining, the increase in DAF fluorescence at 0.5-
1h post-H2O2 treatment was statistically insignificant (Figure 34A). The increase of 
DAF fluorescence was also sustained from 2h to 48h post-H2O2 treatment (Figure 
34B). The increase in DAF fluorescence ranged from 140-240% relative to the 
control. Figure 34C shows an alternate graphical representation of DAF staining. A 
prominent peak of the fluorescence intensity can be observed from the graph. At that 
point (10h post-H2O2 treatment), the increase in DAF fluorescence was 240% relative 












































Figure 34. Nitric Oxide measurement upon H2O2 treatment using the DAF-FM 
Diacetate probe. Cells were treated with 50μM H2O2 for (A) 0.5h and 1h or (B) 2h 
,4h ,6h ,8h ,12h ,24h and 48h, and were incubated with DAF-FM Diacetate for 20min, 
37°C. Green cytosolic fluorescence of 10,000 cells per sample was determined by 
flow cytometry using the FITC-A channel. The data are the means of five 
independent experiments ± S.E.M., *P < 0.05, as compared to control at respective 
time points.  



































































While DAF is specific for nitric oxide (NO•) detection; DCF detects a wide range of 
ROS. Based on the specificity of the dyes, we deduced the possible species of ROS 
and RNS produced: DCF detects peroxyl radical (ROO•), hydroxyl radical (OH•), 
peroxynitrite (ONOO
-
) and H2O2, while DAF detects NO•. Next, we predicted that as 
the immediate product of H2O2 in the Fenton’s reaction, OH• was involved in caspase 
3 activation. Surprisingly, pre-incubation of cells with Dimethylthiourea (DMTU), a 
potent OH• scavenger had no effect on H2O2-induced caspase 3 activation. This is 
with regard to both caspase 3 activity (Figure 35A) and caspase 3 cleavage (Figure 
35B). Eliminating OH•, we next assessed the possibility of ONOO- and NO• 









Figure 35. Scavenging OH• did not prevent caspase 3 activation.  L6 myoblasts 
were pre-treated with increasing dose of DMTU before exposure to 50μM H2O2. At 
24h post-H2O2 treatment, cells were harvested for (A) caspase 3 activity assay and (B) 

























































Cells were incubated with a peroxynitrite decomposition catalyst, FeTPPS, before 
treatment with H2O2. Incubation with FeTPPS abrogated caspase 3 activation and 
cleavage in a dose-dependent manner (Figure 36). Besides caspase 3 activity, LMP 






Figure 36. H2O2-mediated caspase 3 activation required ONOO
-
.  L6 myoblasts 
were pre-treated with various doses of peroxynitrite decomposition catalyst, FeTPPS, 
before exposure to 50μM H2O2. At 24h post-H2O2 treatment, cells were harvested for 
(A) caspase 3 activity assay and (B) Western Blot analysis. The data are the means of 
three independent experiments ± S.E.M., *P < 0.05. Western Blot shown is 



























































Figure 37. LMP was inhibited by ONOO
-
 chelation. Cells were exposed to 10μM 
Acridine Orange and 50μM FeTPPS for 30 min at 37°C, before cells were treated 
with 50μM H2O2 for 4 hours. Green cytosolic fluorescence of 10,000 cells per sample 
was determined by flow cytometry using the FITC-A channel. (A) The data are the 
means of three independent experiments ± S.E.M., *P < 0.05. (B) A representative 



























































NO• chelation was achieved by cPTIO. At 100µM and 200µM, pre-treatment with 
cPTIO decreased caspase 3 activation by H2O2, but was not able to arrest it 
completely. At 200µM, cPTIO decreased H2O2-induced caspase 3 activity from 7 to 3 
fold, a reduction close to 60% (Figure 38). We did not increase the dose of cPTIO 
over 200µM because a higher dose resulted in cell death (data not shown). cPTIO also 
did not inhibit LMP completely. Using 200µM cPTIO, a 60% reduction (from 118% 




Figure 38. NO• chelation inhibited caspase 3 activation by H2O2 treatment. Cell 
were pre-treated with 10, 20, 50 100 or 200μM nitric oxide chelator, cPTIO, for 2h 
before exposure to 50μM H2O2.  After 24h, cells were harvested for caspase 3 activity 
assay analysis. The data are the means of three independent experiments ± S.E.M., *P 

















































Figure 39. LMP was inhibited by NO• chelation. Cells were exposed to 10μM 
Acridine Orange and 200μM cPTIO for 30 min at 37°C, before cells were treated with 
50μM H2O2 for 4h. Green cytosolic fluorescence of 10,000 cells per sample was 
determined by flow cytometry using the FITC-A channel. (A) The data are the means 
of three independent experiments ± S.E.M., *P < 0.05.  (B) A representative flow 






























































In summary, results in this section showed that caspase 3 activation by H2O2 was 
redox-regulated. Iron, peroxynitrite and nitric oxide were required for LMP and 
caspase 3 activation.  While iron was only required in the first hour of reaction, 
constant presence of peroxynitrite was required for sustained caspase 3 activation. 
Figure 40 showed the summarized pathway of the redox-regulated caspase 3 




Figure 40. Iron, ONOO
-
, and NO• were upstream of LMP and caspase 3 
activation. Upon H2O2 treatment, there was an increase in ROS/RNS level from 2-
48h. Such increase in ROS/RNS level was postulated to be iron-dependent. Iron, 
ONOO
-
, and NO• were found to be inducing LMP leading to caspase 3 activation. 





















3.2.3 H2O2-induced caspase 3 activation is p53-dependent 
As a key regulator of cell fate, p53 is the master gene that response to various stress 
signals including oxidative stress and DNA damage. As a tumour suppressor, p53 
plays pivotal role in the cell protective mechanism to genome instability. For 
example, in case of DNA damage, the p53-mediated DNA damage responses pathway 
is activated. Such p53-meadiated response elicits diverse responses, ranging from cell 
growth arrest, cellular senescence and apoptosis.  
 
On the other hand, ROS is known to be one of the major sources of DNA damage. 
ROS has the ability to modify cellular biomolecules, including DNA, leading to DNA 
damage and dysfunction. For example, DNA base damage is caused by the reaction of 
hydroxyl radicals with DNA bases through the mechanisms of addition and 
abstraction, which leads to the formation of various OH-adduct radical of bases
142
. 
Through the same mechanisms, hydroxyl radicals attack the DNA sugar and cause 
DNA sugar damage
142
. Similar to OH•, ONOO- is able to cause oxidative 
modification to DNA bases, particularly Guanine, and the sugar-phosphate 
backbone
143
. The effect of NO• on DNA damage is mostly mediated through its 
oxidation product with O2, N2O3
143,144
. N2O3 cause DNA damage through nitrosation 
of amines on DNA bases, eventually leads to deamination of the bases. The change in 
structure caused by deamination converts the original base to a different molecule. 
The potential consequences of such change are base mutation or single strand breaks, 
depending on the modified nucleoside
143
.     
 
Nevertheless, the response of p53 to ROS is not limited to ROS-induced DNA 
damage, but depends on the level of oxidative stress instead. At low level of oxidative 
109 
 
stress, p53 plays an antioxidant role and promote cell survival
145
. At high level of 




Based on these arguments, it is natural to assume that p53 is involved in our system. 
Firstly, H2O2 treatment resulted in DNA damage as evident by the phosphorylation of 
γ-H2AX and increased comet tail length in the comet assay (Appendix A). Secondly, 
H2O2 treatment resulted in cell growth arrest (Figure 2). Thirdly, H2O2 treatment 
induced a pro-oxidant state in cell with sustained production of ROS and nitric oxide 
(Figure 33 and 34). Hence, we explore the possibility of p53 is involved in the 
activation of caspase 3. 
 
3.2.3A H2O2 treatment resulted in activation of p53 
The two benchmarks of p53 activation is an increase in the protein level of p53, 
caused by the stabilization of the p53 protein
146
, and phosphorylation of p53 at serine 
15
147,148
. The phosphorylation site serine 15 was also reported to be phosphorylated 
during oxidative stress. For example, Chen et al. has shown that 100µM H2O2 leads to 
p53 phosphorylation on Ser-15 in an ATM kinase-dependent manner, resulting in p53 






To investigate the involvement of p53 in our system, we first looked at p53 protein 
expression after H2O2 treatment. Western Blot analysis showed that, upon H2O2 
treatment, there was an increase in the expression level of total p53 protein as well as 
the phosphorylation level at serine 15 (Figure 41A). Densitometric analysis of five 
independent experiments revealed a decreasing pattern in p53 protein expression over 
time after the first hour (Figure 41B). At 1 hour post-H2O2 treatment, the increase in 
110 
 
p53 protein level was 1.4 fold of the control. There was a gradual decline in the 
protein level after 1 hour, and at 9h, p53 protein level was reduced to basal level.  
 
Densitometric analysis of p53 phosphorylation level (as normalized to loading control 
β-actin) showed that phosphorylation at serine 15 was increased from 1h to 24h post-
H2O2 treatment (Figure 41C). Maximum phosphorylation was observed at 1h and 3h, 
with an increase of approximately nine folds relative to the control. After the 
maximum phosphorylation at 3h, the phosphorylation level steadily decreased. At 
48h, the phosphorylation level decreased to basal level.  When we normalized the 
phosphorylation level to total p53 protein level, a peak of phosphorylation was 
observed at 3h (Figure 41D). This is due to higher p53 protein level at 1h as compared 
to 3h. When normalized to total p53 protein level, the increase in phosphorylation 
level was 5.2 fold and 9.2 fold at 1h and 3h respectively. After 3h, the 
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Figure 41. H2O2 treatment induced phosphorylation of p53 at ser15. (A) L6 
myoblasts were treated with 50μM H2O2 for indicated time points and were harvested 
for Western Blot analysis of p53 protein level.  Western Blot shown is representative 
of five independent experiments.  
 
Densitometric analysis of (B) total p53 protein expression, normalized to loading 
control β-actin, (C) p53 phosphorylation level on ser15, normalized to loading control 
β-actin, (D) p53 phosphorylation level on ser15, normalized to the densitometric 
value of total p53 protein expression as calculated in (B). The change in total p53 
protein expression and phosphorylation level was shown as a fold difference relative 
to control cells at respective time points. The data are the means of five independent 













































3.2.3B Inhibition of p53 decreased H2O2-induced caspase 3 activation 
Having shown that p53 was activated upon H2O2 treatment, we then examined the 
effect of such activation on caspase 3 activation. p53 was silenced by specific siRNA 
before cells were treated with 50µM H2O2. At 24h post-H2O2 treatment, cells were 
harvested for caspase 3 activity assay and Western Blot analysis. It was found that 
silencing of p53 resulted in decrease in caspase 3 activity (Figure 42A) and caspase 3 
cleavage (Figure 42B). However caspase 3 activity was not completely inhibited by 
p53 silencing. In case of p53 knock down, the activity of caspase 3 decreased from 
4.3 fold to 2.7 fold, a decrease of less than 50% (Figure 42A). It is also noted that 
silencing of p53 alone resulted in caspase 3 cleavage, although the reason and 
possible outcome of this caspase 3 activation is yet to be investigated (Figure 42B). 
Such caspase 3 activation effected by p53 knock down did not affect cell morphology 
and cell density. Instead, the decrease in cell density by H2O2 treatment was reverted 
by knock-down of p53 (Figure 42C). The results support that p53 was responsible for 
H2O2-induced cell growth arrest. Nevertheless, analysis by the densitometry of the 
Western Blot of p21, the reported downstream gene in of p53 in p53-mediated cell 
cycle arrest pathway, showed no increase in protein expression over time (Figure 43). 
This further supported our earlier deduction that decreased proliferation of H2O2-
treated cells was not due to cell cycle arrest. Finally, silencing of p53 prevented LMP 
event at 4h post-H2O2 treatment (Figure 44). However, the inhibition of LMP by p53 
































































Figure 42. Knock-down of p53 decreased caspase 3 activation by H2O2 
treatment.  L6 myoblasts were transiently transfected with siRNA specific to p53 
(sip53) or negative control siRNA (siCo) for 24 hours before exposure to 50μM H2O2. 
After 24 hours, cells were harvested for (A) caspase 3 activity assay and (B) Western 
Blot analysis. The data are the means of three independent experiments ± S.E.M., *P 
< 0.05.  Western blot is representative of three independent experiments.  
(C) Cell morphology was observed under a phase contrast microscope. Pictures 











Figure 43. p21 expression upon H2O2 treatment. (A) L6 myoblasts were treated 
with 50μM H2O2 for indicated time points and were harvested for Western Blot 
analysis of p21 protein level. Western Blot shown is representative of five 
independent experiments. 
(B) Densitometric analysis of p21 expression, normalized to loading control β-actin. 
The change in p21 protein expression was shown as a fold difference relative to 
control cells at respective time points. The data are the means of five independent 
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Figure 44. LMP was inhibited by p53 knock-down. Cells were transiently 
transfected with siRNA specific to p53 (sip53) or negative control siRNA (siCo). At 
24h post-transfection, Cells were exposed to 10μM Acridine Orange for 30 min at 
37°C, before cells were treated with 50μM H2O2 for 4h. Green cytosolic fluorescence 
of 10,000 cells per sample was determined by flow cytometry using the FITC-A 
channel. (A) The data are the means of three independent experiments ± S.E.M., *P < 
0.05. (B) A representative flow cytometry histogram from three experiments is 
shown. (C) Western Blot indicating knock-down efficiency of p53 is representative of 











































































We next assessed the cellular localization of phosphorylated- and total p53 (Figure 
45). In L6 myoblasts, p53 protein was detected in the nucleus and cytoplasm, with the 
protein found primarily in the nucleus (Figure 45). Although not detected in the 
previous Western Blot, but when under a higher exposure and with higher amount of 
protein loaded, it was found that nuclear p53 was phosphorylated at serine 15 at 
normal untreated condition. Upon H2O2 treatment, the phosphorylation further 
increased for both nuclear and cytoplasmic pool of p53. The amount of 





Figure 45. H2O2 treatment resulted in increase in phosphorylation of both the 
cytosolic and the nuclear p53. Cells were exposed to 50μM H2O2 for 1h or 4h, and 
were subjected to cytoplasmic-nuclear fractionation and subsequently Western Blot 
analysis. Lamin B1 is the marker for nuclear fraction and Superoxide Dismutase 1 
(SOD1) is the marker for cytoplasmic fraction. Western Blot shown is representative 
of two independent experiments. (C: Cytosolic, N: Nuclear).  
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3.2.3C p53 mediated caspase 3 activation via its non transcriptional pathway 
As a transcription factor, p53 can promote apoptosis by transcriptional activation of 
the pro-apoptotic genes of the Bcl-2 family
150
, or by transcriptional repression of anti-
apoptotic genes, such as survivin
151
. Although controversial, the transcriptional-
independent role of p53 in apoptosis has also been proposed. The mechanism of p53 
non-transcriptional role in apoptosis mainly involves the intrinsic pathway. It has 
been reported that a cytoplasmic localized p53 could directly activate Bax, leading to 
its translocation into the mitochondria
152
. A mitochondrial localized p53 could 
physically interact with Bcl-XL and Bcl-2, thereby suppressing their anti-apoptotic 
properties
153
. Eventually, the p53 non-transcriptional apoptosis mechanism initiates 
MOMP and subsequently activates the caspase cascade. Figure 46A showed a simple 
illustration of the proposed models of p53-mediated apoptosis, via the transcriptional 
or non-transcriptional mechanisms. 
 
When cells were treated with 50µM H2O2, p53 was activated. This activation of p53 
was responsible for inducing LMP and subsequently leading to caspase 3 activation. 
We hypothesized that caspase 3 activation induced by p53 could be dependent or 









Figure 46. p53 pathway in H2O2-induced caspase 3 activation could be 
transcriptional-dependent or –independent. (A) The established p53-dependent 
pathway in apoptosis. p53 could have a transcriptional-dependent role in apoptosis, by 
up-regulating pro-apoptotic genes that facilitate the event of MOMP and caspase 
cascade activation. The transcriptional-independent role of p53 in apoptosis lies in its 
ability to directly induce MOMP, leading to caspase cascade activation and apoptosis. 
(B) Hypothesized pathways of p53-dependent caspase 3 activation upon 50μM H2O2 
treatment. Pifithrin-α was used to determine if p53 could activate caspase 3 through a 























To test the non-transcriptional activity of p53 in our system, we pre-incubated the 
cells with Pifithrin-α (PFT), a small molecule inhibitor of p53 transcriptional 
activity
154
, and examined caspase 3 cleavage and activity upon H2O2 treatment. p21 
expression was greatly reduced in cells treated with PFT (Figure 47B), this is similar 
to the effect on p21 expression with p53 silencing (Figure 47A). This proves that p53 
transcriptional activity was inhibited by PFT. However, in the same Western Blot, 
caspase 3 cleavage was not prevented by pre-treatment with PFT (Figure 47B). 
Moreover, caspase 3 activity assay confirmed that H2O2-induced caspase 3 activation 
was unaffected by PFT (Figure 47C).  
 
These results were in contrast with our earlier findings in that silencing of p53 could 
inhibit both caspase 3 cleavage and activity (Figure 42). In view of the results, we 
proposed that p53-mediated caspase 3 activation in our system was transcriptional-

































Figure 47. Inhibiting transcriptional activity of p53 by Pifithrin-α (PFT) did not 
prevent caspase 3 activation.  (A) L6 myoblasts were transiently transfected with 
siRNA specific to p53 (sip53) or negative control siRNA (siCo) for 24h before 
exposure to 50μM H2O2. After 24h, cells were harvested for Western Blot analysis of 
p21 expression. (B) Cells were pre-treated with 50μM PFT before exposure to 50μM 
H2O2. 24 hours post-H2O2 treatment, cells were harvested for Western Blot analysis 
of caspase 3 cleavage and p21 expression. Western Blots shown are representative of 
two independent experiments. (C) Cells were pre-treated with increasing dose of PFT 
before exposure to 50μM H2O2. At 24h post-H2O2 treatment, cells were harvested for 
caspase 3 activity assay analysis. The data are the means of three independent 
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3.2.3D p53 activation upon H2O2 treatment was ROS/RNS dependent 
As shown in Figure 48, LMP-caspase 3 activation and H2O2 was connected by a p53- 
and ROS/RNS-mediated pathway. Both p53 and ROS/RNS were upstream of the 
LMP-caspase 3 activation. The activation of p53 and production of ROS/RNS could 
be detected as early as 1-2 h. The relation between p53 and ROS is an interdependent 
one. While ROS can be the upstream signal that triggers p53 activation, it is also 
generated as part of the p53 downstream signalling pathway
145
. To understand the 
relation between p53 and ROS/RNS in our system, we inhibit p53 to examine its 





Figure 48. The relation between p53 and ROS/RNS as upstream activators of 
H2O2-induced caspase 3 activation. As upstream activators of LMP and caspase 3, 
the position of p53 and ROS/RNS in the pathway is not yet determined. Activation of 












Cells were pre-treated with 20µM iron chelator, DFP and were harvested for Western 
Blot analysis of p53 expression at 1h, 5h and 12h post-H2O2 treatment. Pre-incubation 
with DFP decreased p53 phosphorylation significantly at the three time points 
measured (Figure 49). The same was observed for cells pre-treated with the 
peroxynitrite decomposition catalyst, FeTPPS. There was a decreased in 
phosphorylation of p53 at 1h, 5h, and 12h post-H2O2 treatment (Figure 50). In 
comparison, p53 phosphorylation was relatively unaffected by cPTIO (Figure 51). 
The inhibitory effect of FeTPPS on p53 phosphorylation at 1h was rather surprising. 
Indeed, as previously shown in Figure 33A, although there was an increase in DCF 
fluorescence at 1h, such increase was statistically insignificant due to variation 
between independent experiments. This suggests that minute amount of peroxynitrite 




Figure 49. Iron chelation decreased p53 phosphorylation. Cells were pre-treated 
with 20μM iron chelator DFP for 2h before exposure to 50μM H2O2. Cells were 
harvested at indicated time points for Western Blot analysis. Western Blot shown is 
representative of three independent experiments.  
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Figure 50. Peroxynitrite chelation decreased p53 phosphorylation. Cells were pre-
treated with 50μM FeTPPS for 2h before exposure to 50μM H2O2. Cells were 
harvested at indicated time points for Western Blot analysis. Western Blot shown is 




Figure 51. Nitric Oxide chelation had minimal effect on p53 phosphorylation. 
Cells were pre-treated with 100μM nitric oxide chelator, cPTIO for 2h before 
exposure to 50μM H2O2. Cells were harvested at indicated time points for Western 
Blot analysis. Western Blot shown is representative of two independent experiments. 
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Next, we silenced p53 and harvested the cells for DCF and DAF staining analysis. 
Figure 52 showed the ROS and RNS production in cells transfected with sip53 or 
negative control siRNA after H2O2 treatment. The percentage of DCF and DAF 
fluorescence was normalized to their respective control (i.e. to cells transfected with 
sip53 or negative control siRNA, without H2O2 treatment). Results showed that at 2h 
and 4h, both ROS and nitric oxide production upon H2O2 treatment was unaffected by 
p53 silencing (Figure 52). At 12h post-H2O2 treatment, it was observed that p53 
knock-down cells had higher ROS production compared to negative control siRNA-
transfected cells (Figure 52A).  On the other hand, nitric oxide production at 12h was 










































Figure 52. H2O2-induced ROS/RNS production was unimpeded by p53 knock-
down. L6 myoblasts were transiently transfected with siRNA specific to p53 (sip53) 
or negative control siRNA (siCo) for 24h before exposure to 50μM H2O2. At 2h, 4h, 
and 12h post H2O2 treatment, cells were harvested for (A) CM-H2DCFDA and (B) 
DAF-FM staining. Green cytosolic fluorescence of 10,000 cells per sample was 
determined by flow cytometry using the FITC-A channel. The data are the means of 
two independent experiments ± Sd, normalized to control (sip53 or siCo, without 
H2O2 treatment) at respective time points. (C) Western Blot indicating knock-down 












































3.3 An alternative function of caspase 3 activation in absence of cell 
death 
We have demonstrated an alternative pathway of caspase 3 activation during 
oxidative stress by H2O2. H2O2- and STS-induced caspase 3 activations differed in 
terms of time of activation, magnitude of activation and also their dependency on the 
upstream initiator caspases for activation. The different upstream pathways leading to 
caspase 3 activation in H2O2 and STS treatment is presented in Figure 53. While it is 
highly likely that STS induced caspase 3 activation is via the classical extrinsic 
pathway, H2O2-induced caspase 3 activation was shown to be ROS and p53 
dependent. Also, such activation requires LMP and the release of cathepsin B and L. 
More importantly, not only was caspase 3 activated via a non-classical pathway, H2O2 
treatment did not result in apoptosis. 
 
We need to ask if this alternative activation pathway is simply a redundant pathway 
for caspase 3 activation or does caspase 3 have a different function when activated via 
this pathway; especially since its has been shown in our study that cell death does not 





Figure 53. Alternative function of activated caspase 3 in non-apoptotic condition. 
While STS treatment resulted in caspase 3 activation and apoptosis, H2O2 treatment 
resulted in caspase 3 activation without inducing cell death. While activated caspase 3 
in STS treatment cleaved the classical apoptotic substrates such as PARP, Lamin A/C 
and Gelsolin; activated caspase 3 in H2O2 treatment did not result in such cleavage 
(Appendix B). With the distinct difference with STS-activated caspase 3 in terms of 
upstream pathway, cleavage of substrates as well as localization of the activated 
































3.3.1 H2O2-induced caspase 3 activation was involved in lysosomal biogenesis 
3.3.1A H2O2 treatment resulted in an increase in lysosome biogenesis 
When we incubated the cells with LysoTracker® Red DND-99, under the confocal 
microscope, we observed a significant increase in the lysotracker staining over time in 
cells treated with H2O2, especially at 12h, 24h and 48h post-treatment (Figure 54A). 
The increase in lysotracker staining indicates increase in lysosome numbers which 
also suggesting an increase in lysosome biogenesis. A quantitative measurement of 
such lysosomes increase was obtained when cells were stained with LysoTracker® 
Red DND-99 and the red lysosomal fluorescence was assessed by FACS analysis 
(Figure 54B). Result shows that there was a gradual increase in relative fold of 
lysotracker fluorescence intensity of H2O2-treated cells as compared to the control 
cells at 8–48h (Figure 54B). The same trend of fluorescence increment was observed 
when cells were stained with Acridine Orange, a metachromatic dye that exhibit a red 
fluorescence when accumulates in lysosomes. When measured by FACS analysis, it 
was shown that the Acridine Orange-induced red lysosomal fluorescence steadily 
increased from 8-48h (Figure 54C).  Together, the results confirmed that H2O2 




















Figure 54. H2O2 treatment resulted in time-dependent increase in lysosome 
biogenesis. Cells were treated with 50μM H2O2 for indicated time points and were 
incubated with a diluted LysoTracker® Red DND-99 solution (75nM) for 45min, 
37°C. (A) After fixation, red lysosomal fluorescence was analyzed under the confocal 
microscope. (B) Red lysosomal fluorescence of 10,000 cells per sample was 
determined by flow cytometry using the PerCP-A channel. The data are the means of 
two independent experiments with duplicates ± SD.  
(C) Cells were treated with 50μM H2O2 for indicated time points and were exposed to 
an Acridine Orange solution (10μM) for 30min, 37°C at 24h post-H2O2 treatment. 
Red lysosomal fluorescence of 10,000 cells per sample was determined by flow 
cytometry using the PerCP-A channel. The data are the means of four independent 



































































































3.3.1B Inhibition of caspase 3 decreased H2O2-induced lysosome biogenesis 
When cells were pre-incubated with QVD-OPH, a broad spectrum caspase inhibitor 
prior to H2O2 treatment and LysoTracker® Red DND-99 staining, it was found that 
this pre-incubation with QVD-OPH could greatly reduce the increase in lysotracker 
staining due to H2O2 (Figure 55A). Such decrease in lysotracker staining was also 
achieved by pre-treatment of cells with the caspase 3-specific inhibitor, zDEVD-FMK 
(Figure 55B). Finally, we silenced caspase 3 and measured the Acridine Orange 
staining by flow cytometry 24 hours after H2O2 treatment (Figure 55C). Upon caspase 
3 knock-down, H2O2-induced increase in Acridine Orange red fluorescence was 
decreased from 148% to 124%. In conclusion, we deduced that increase in lysosome 





















































































Figure 55. Effect of caspase 3 inhibition on H2O2 – induced lysosome biogenesis. 
L6 myoblasts were pretreated with (A) 10µM QVD-OPH or (B) 20µM zDEVD-
FMK, for 2 hours before treated with 50μM H2O2 for 24 hours. Cells were then 
exposed to a diluted LysoTracker® Red DND-99 solution (75nM) for 45min, 37°C.  
After fixation, red lysosomal fluorescence was analyzed under confocal microscope. 
Immunofluorescence images are representative of two independent experiments.  
(C) Cells were transiently transfected with siRNA specific to caspase 3 (siC3) or 
negative control siRNA (siCo). Cells were treated with 50μM H2O2 at 24 hours post-
transfection. At 24h post-H2O2 treatment, cells were exposed to 10μM Acridine 
Orange for 30 min at 37°C, Red lysosomal fluorescence of 10,000 cells per sample 
was determined by flow cytometry using the PerCP-A channel. The data are the 
means of three independent experiments ± S.E.M., *P < 0.05. Western Blot indicating 
knock-down efficiency of caspase 3 is representative of three independent 
experiments. (D) A representative flow cytometry histogram from three experiments 









The transcription factor for EB (TFEB) had been identified as the master gene for 
lysosomal biogenesis
155
. TFEB over expression in cultured cells resulted in increased 
lysosomal biogenesis as well as cellular clearance of macromolecules such as 
glycosaminoglycans
155
. Recent findings suggest that TFEB translocates into the 
nucleus to initiate lysosomal biogenesis and lysosomal gene transcription. In our 
system, when cells were treated with 50µM H2O2, there was an enhanced nuclear 
localization of TFEB (Figure 56A). As a comparison, cytoplasmic staining of TFEB 
was observed in the control untreated cells. H2O2 treatment not only resulted in 
translocation of TFEB, but also increased the overall expression of TFEB. This was 
shown as the higher fluorescence intensity of TFEB in the treated cells compared to 
the control cells.  
 
 Although the role of caspases in lysosomal biogenesis was unreported, we speculate 
that caspase 3 might be involved in the TFEB pathway. We pre-incubated the cells 
with a pan caspase inhibitor QVD-OPH and the caspase 3-specific inhibitor zDEVD-
FMK before H2O2 treatment. In the presence of both inhibitors, the increase in TFEB 
expression as well as the nuclear translocation of TFEB was greatly reduced (Figure 
56B and 56C). The result supports a potential role of caspase 3 in lysosomal 
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Figure 56. Caspase 3 inhibition impeded TFEB up-regulation and nuclear 
translocation. (A) L6 myoblasts were treated with 50μM H2O2 24 hours. After 
fixation, cells were incubated with primary antibody specific to TFEB followed by 
confocal microscopy analysis. Immunofluorescence images shown are representative 
of three independent experiments. Negative control refers to samples incubated in 
blocking buffer without primary antibody.  
Cells were pretreated with (B) 10µM QVD-OPH or (C) 20µM zDEVD-FMK, for 2 
hours before treated with 50μM H2O2 for 24 hours. Cells were then were incubated 
with TFEB specific primary antibody followed by confocal microscopy analysis. 
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3.3.2 NHE-1 promoter activity was unaffected by caspase 3 activation  
Our previous study in lab demonstrated a new role of caspase 3 in sustaining 
repression of protein expression upon mild oxidative stress and in the absence of cell 
death. In a serum starved condition, 50µM H2O2 treatment on L61.1 cells resulted in 
caspase 3 activation that subsequently led to NHE-1 gene repression
104
. Without 
activation of caspase 3, H2O2 elicited a mild oxidative stress that resulted in transient 
and reversible inhibition of the NHE-1 promoter activity, but was insufficient to effect 
down-regulation of protein levels. With the activation of caspase 3, a sustained 




As the finding was performed in a serum starvation condition, it was of interest to 
examine the effect of caspase 3 activation on NHE-1 promoter activity in our system, 
in which cells were cultured and treated in 10% FBS medium. The study of NHE-1 
promoter activity could be easily performed as the same cell line was used in our 
study. L6 myoblasts were stably transfected with the full length 1.1kb proximal 
fragment of the mouse NHE-1 gene promoter, which was inserted 5’ to the luciferase 
gene (Figure 57)
108
. NHE-1 promoter activity was quantified by the luciferase enzyme 







Figure 57. Stable expression of the full length 1.1kb mouse NHE-1 gene 
promoter by L6 myoblasts. L6 myoblasts were stably transfected with the full length 
1.1kb proximal fragment of the mouse NHE-1 gene promoter which inserted 5’ to the 
luciferase reporter gene. Therefore, NHE-1 gene promoter activity can be quantified 
using the luciferase assay as the production of luciferase enzyme is correlated to the 
activity of NHE-1 promoter.  
 
 
NHE-1 promoter activity was decreased in a dose-dependent manner when cells were 
exposed to increasing dose of H2O2 (Figure 58A). Similar finding was observed with 
cells treated with H2O2 in a serum starved condition, a dose-dependent decrease in 
NHE-1 promoter activity was achieved by addition of H2O2 (Figure 58B). Notably, 
such decrease in NHE-1 promoter activity required twice as much dose in cells treated 
in 10% FBS than the serum starved cells. For example, while 50µM H2O2 treatment 
induced a 40% decrease in NHE-1 promoter activity in cells treated in physiological 
condition (10% serum), such decrease could be achieved with 25µM H2O2 in serum-
starved cells. 
  











Figure 58. H2O2 down-regulated NHE-1 promoter activity in a dose-dependent 
manner. (A) Cells were treated with increasing doses of H2O2 for 24 hours and were 
harvested for luciferase assay to quantify NHE-1 promoter activity. (B) Cells were 
serum-starved over night before treatment with increasing doses of H2O2 for 24 hours. 
Cells were then harvested for luciferase assay to quantify NHE-1 promoter activity. 






































































To see if caspase 3 was involved in NHE-1 gene repression in our system, we 
inhibited caspase 3 activity with the pan caspase inhibitor QVD-OPH and caspase 3 
inhibitor zDEVD-FMK and examined NHE-1 promoter activity. At 48h, a recovery in 
NHE-1 promoter activity was observed, as compared to that at 24h (Figure 59A). It is 
found that both QVD-OPH and zDEVD-FMK was unable to rescue NHE-1 promoter 
activity repression by H2O2 (Figure 59A). As the dose of QVD-OPH and zDEVD-
FMK was sufficient to inhibit caspase 3 activity induce by H2O2 (Figure 59B), we 









Figure 59. H2O2-induced down-regulation of NHE-1 promoter activity was 
unaffected by caspase 3 inhibition. Cells were pre-treated with 10μM QVD-OPH or 
20µM zDEVD-FMK before exposure to 50μM H2O2. (A) After 24h and 48h, cells 
were harvested for luciferase assay. The data are the means of three independent 
experiments ± S.E.M. (B) At 24h post-H2O2 treatment, cells were harvested for 














































































CHAPTER 4 DISCUSSION 
For a long time, caspases activation has been solely implicated in apoptosis. In recent 
years, increasing numbers of studies are dedicated to understanding the alternative 
roles of caspases in a physiological context beyond apoptosis, particularly in cellular 
function and development. Our present study is a valuable example of how caspase 3 
is involved in a non-apoptotic role. Based on the previous study by Kumar et al.,
104
 
we pursued the upstream pathway leading to caspase 3 activation in a non-apoptotic 
condition. 
 
Our present study demonstrated that transient exposure to H2O2 can elicit an 
elaborated and complicated signalling response, leading to caspase 3 activation. In our 
system, caspase 3 was activated independently of the initiator caspases. The activation 
of caspase 3 was, instead, mediated by peroxynitrite, nitric oxide and p53, which 
converged on the occurrence of lysosomal membrane permeabilization (LMP). As a 
result of LMP, cathepsin B and L are released into the cytosol. We postulated that 
cathepsin B and L could directly cleave and activate caspase 3 in our system. Lastly, 
we also proposed a novel role of caspase 3 in lysosome biogenesis by regulating the 




4.1 H2O2 induced caspase 3 activation by a non classical pathway in the 
absence of cell death  
ROS are one of the most important inducer/mediator in apoptosis
156
. Studies that 
manipulated oxidation level and intracellular antioxidant system have clearly affirmed 
the roles of ROS in apoptosis based on the following observations: (1) Exogenous 
addition of ROS or depletion of intracellular antioxidants resulted in apoptosis in 
various cell types
157-159
 (2) Many apoptotic drugs generate ROS that compromise the 
mitochondrial membrane integrity, leading to cytochrome c release and caspase 
activation, and subsequently cell death. (3) In these cases, apoptotic drugs-induced 
apoptosis can be inhibited by antioxidants, ROS scavengers or over-expression of 
antioxidant genes
158,160,161





 are redox-regulated. (5) Increase in intracellular ROS is a 




ROS are one of the most reproducible inducers of caspases cascade, although its exact 
mechanism is yet to be clearly illustrated. As caspases are cysteine-dependent 
proteases, it is also expected that they might be redox-sensitive and could be redox-
regulated
163
. Despite the mounting evidences of ROS involvement in apoptosis, ROS 
inhibition of apoptosis was also well reported. For example, although ROS level was 
often elevated in apoptotic cells, prolonged or excessive oxidative stress can actually 
prevent caspase activation
163
. Generally, low level of ROS leads to cell survival and 
proliferation, moderate level of ROS results in apoptosis, high level of ROS results in 
massive cell death or necrosis. Figure 60 summarizes the effect of ROS on caspase 








Figure 60. Redox regulation of caspase activation. Caspases can be activated or 
inhibited by ROS, depending on the concentration and species of ROS in action. (A) 
ROS induces caspases activation via multiple pathways that are non-exclusive, 
leading to apoptosis. (B) Caspases contain redox-sensitive residues that can be 
modified by ROS. Common redox modifications of caspases are s-nitrosylation, 
oxidation and glutationylation. Often, these redox modifications lead to inactivation 






















Exogenous H2O2 is widely used in studies where oxidant-dependent signalling is 
concerned. Compared to its derivatives such as OH•, H2O2 traverse the membranes 
readily and survives long enough to induce a redox change distant from its site of 
production
166
. Therefore, H2O2 is a convenient tool to induce oxidative stress. Many 
studies have utilized exogenous H2O2 to induce caspase 3 activation and most of these 
reports focused on H2O2 inducing apoptosis by activating the caspase cascade. 
Nevertheless, this does not mean that H2O2 or ROS necessarily activates caspase and 
results in cell death. It should be noted that negative results were often less reported 
than positive results. In our study, H2O2 induced activation of caspase 3 in absence of 
cell death. Compared to the classical inducer of apoptosis, STS-induced and H2O2-
induced caspase 3 activation were different in several aspects.  
 
STS induces caspase 3 activation through the intrinsic pathway, as evident by the 
temporal pattern of caspases activation and the inhibitory effect of zVAD-FMK and 
zLEHD-FMK on caspase 3 activation.  Amplification of the caspase cascade was also 
observed with the activation of caspase 8 a few hours after caspase 3 activation. In 
contrast, there was no activation of caspase 8 and caspase 9 when cells are exposed to 
50µM H2O2. H2O2-induced caspase 3 cleavage was unimpeded by the caspases 
inhibitors. Also, although caspase 3 was activated, there was no amplification of the 
caspase cascade. In term of localization, activated caspase 3 in STS system was 
detected in both nucleus and cytoplasm, while activated caspase 3 in H2O2 system 
was mainly detected in the nucleus.  In comparison with the caspase 3 activation of 
STS, the magnitude of H2O2-induced caspase 3 activation was much lower and started 
much later. Lastly, while STS-induced caspase 3 contributed to apoptosis, H2O2-
150 
 
induced caspase 3 did not result in apoptosis. Together, these differences outline a 
unique pathway of caspase 3 activation during mild oxidative stress. 
  
In recent years, there have been new evidence of caspases activation and cleavage of 
their substrates in the absence of cell death, demonstrating caspases’ alternative roles 
in cellular physiological functions beyond apoptosis
167
. To dates, non-apoptotic roles 
of caspases have been reported in inflammatory response
168
, immune cell 
proliferation
169,170
, and differentiation of various cell types
40,41,48
.  The ability of 
caspase to carry out its non-apoptotic roles relies on various mechanisms that act 
singularly or in combination for restricted cleavage and limiting execution of 
apoptosis (Figure 61).  For our study, we demonstrate that caspase 3 activated during 
mild oxidative stress happen in the context of cell survival and could have a non-
apoptotic purpose. We also outlined several distinct features of the caspase 3 
activation in our system, these are: a caspase-independent upstream pathway, 
sustained nuclear localization, and low concentration of caspase 3 activity. These 
distinct features could be important regulatory mechanisms for caspase 3 to execute 





Figure 61. Caspases’ functions in cell survival and cell death require extensive 
regulatory mechanisms. The key to caspases execution of their non apoptotic 
functions is restricted cleavage of specific target proteins, which is governed by 
caspase activity and accessibility of target proteins. Caspases activity may be 
regulated by post-translational modifications of caspases. Accessibility of the target 
substrate is restricted by specific subcellular compartmentalization of caspases, or 
substrate protection by scaffold proteins or anti-apoptotic factors.  (Adapted from 
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4.1.1 A threshold of caspase 3 activity in apoptosis 
In our study, one striking difference between H2O2 and STS induced caspase 3 
activation is the magnitude of activation. This was measured by the fold of caspase 3 
activity and the amount of cleaved caspase 3 on Western Blot. We postulated that the 
difference in magnitude of caspase 3 activation was a main determinant in cell fate 
decision, i.e. there be a critical activation threshold for caspase 3 to carry out its pro-
apoptotic role. 
 
Studies have shown that low and transient caspase 3 activation could serve a 
physiological role instead of activating the cell death machinery
171,172
. It seems that 
cells can continue to survive in the presence of a certain level of effector caspase 
activity
171
. For example, immunohistochemical study showed that in glioblastoma 
cells, two subsets of cells with different caspase 3 activity was found to have different 
cell fate
32
. The subset of cells with weak to moderate caspase 3 activity does not 
exhibit any apoptotic morphology, while the subset of cells with strong caspase 3 
activity was found with typical apoptotic morphology
32
. The same study also showed 
that NCH89 ex vivo glioblastoma cells have a constitutive, moderate caspase 3 
activity that can be significantly blocked by caspase inhibitors. This constitutive, 
moderate caspase 3 activity was insufficient to induce apoptotic, but was required for 
tumour migration and invasion
32
. When the cells were cultured in vitro, treatment 
with STS was able to further increase the constitutive caspase 3 activity and result in 
apoptosis
32
. This is congruent with our study where low level of caspase 3 activity (by 
50µM H2O2) did not result in apoptosis but high level of caspase 3 activity (by 1µM 




In our study, the difference of the level of caspase 3 activity was also reflected by the 
different subsets of caspase substrate cleaved in H2O2 and STS treatment. We 
examined the protein profile of common substrates of caspase 3 in apoptosis, Lamin 
A/C, PARP, and Gelsolin, and found that they are all cleaved under STS treatment but 
not under H2O2 treatment. We proposed that the level of activated caspase 3 affects its 
ability in substrate cleavage. It has been shown that RasGAP was cleaved 
differentially by different concentration of active caspase 3
67
. Under low 
concentration of active caspase 3, RasGAP was cleaved to generate an N fragment 
that has an anti-apoptotic function. At higher concentrations of active caspase 3, the 
N-fragment is further processed into N1 and N2 fragments, which are pro-apoptotic. 
N1 and N2 fragments potentiate the cells to result in DNA-damage induced apoptosis. 
This differential cleavage of RasGAP seems to be a regulatory mechanism by caspase 
3 to control the extent its own activation in the context of cell survival, as partial 






4.1.2 Sustained nuclear localization of activated caspase 3 
Despite the cytoplasmic localization of its proenzyme form, caspase 3 has been shown 
to be involved in nuclear morphological changes in apoptotic cells
173,174
. A number of 
caspase 3 substrates are also found to be localized in the nucleus
175,176
. It is therefore 
proposed that caspase 3 translocates into the nucleus once it is activated. This 
translocation is an important event during apoptosis.   
 
Several mechanisms have been proposed for the translocation of activated caspase 3 
into the nucleus. An earlier study reported a passive diffusion of activated caspase 3 
into the nucleus in caspase 9-dependent manner
177
, but this was rebutted by recent 
reports. Another study proposed that activated caspase 3 translocates with a substrate-
like protein into the nucleus with the aid of AKAP95 (A-Kinase-Anchoring Protein 
95) as the potential carrier
178
. A more recent study suggested that p3-recognition-
based specific cleavage of caspase 3 disrupts its crm-1-independent nuclear export 
signal, thereby enables its nuclear entry after activation
179
. To date, the exact 
mechanism of caspase 3 nuclear translocation remains elusive.  
 
In our study, time kinetic analysis of immunofluorescence showed that H2O2-induced 
activated caspase 3 had a sustained nuclear localization. At 24h, where the activation 
of caspase 3 by H2O2 was at its maximum, the fluorescence of activated caspase 3 
was observed in the nucleus. Even at 48h, when the fluorescence detection becomes 
more difficult due to the decreased amount of activated enzyme, it was still observed 
in the nucleus.  In comparison, STS-treated cells, at 12h, the fluorescence of activated 
caspase 3 was detected only in the nucleus. At 24h and 48h, both nuclear and 
cytoplasmic localization of activated caspase 3 was detected. Notably, cytoplasmic 
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localization of activated caspase 3 was only found in apoptotic bodies with highly 
fragmented nuclei, while nuclear localization of activated caspase 3 was found in cells 
with condensed nuclei. In apoptotic bodies, activated caspase 3 was found in the 
cytoplasm but not the nucleus. Our study raised two important points: (1) sustained 
nuclear localization of activated caspase 3 for non-apoptotic cells, (2) the relocation 
of activated caspase 3 from nucleus to cytoplasm for apoptotic cells.  
 
The localization of activated caspase 3 in the nucleus could be an important 
mechanism that restricts it from cleaving substrates for apoptosis purpose. This 
feature could have a physiological function. Constitutive expression of activated 
caspase 3 has been found in the nuclei of Bergmann glia and a subpopulation of 
astrocytes in the cerebellar cortex, hippocampus, and spinal cord of rats
180
. Such 
expression of activated caspase 3 was unrelated to apoptosis. Also, PARP, the 
important substrate of caspase 3 during apoptosis, was not cleaved
180
. Another study 
showed that activated caspase 3 was localized in the nuclei of NeuN-positive 
immature neurons in the proliferative regions of immature rat forebrain
52
. These 
activated caspase 3-containing cells were not undergoing apoptosis, but instead was 
dividing and in process of differentiating into mature neurons
52
.   
 
These studies bring out several important messages: firstly, nuclear localization of 
caspase 3 does not necessarily correlate with apoptosis. Secondly, nuclear retention of 
activated caspase 3 could have a physiological relevance. Nevertheless, the exact 
mechanism of how this nucleus-retained caspase 3 exert its non-apoptotic role is still 
unknown. One hypothesis is that caspase 3 could be participating in secondary 
processing of transcription factors. Several transcription factors from the FOXO 
156 
 
family contain conserved caspase 3 cleavage site
181
. Also, Kumar et al. showed that 
nuclear localization of caspase 3 was essential for ROS production and down-




It has also been shown that altered nuclear event (i.e. nuclear fragmentation and 
condensation) was dependent on caspase 3 activation. Caspase 3 deficient cells 
undergo apoptosis without nuclear fragmentation
174
. The cleavage of NuMA and 
Lamin A/C by caspase 3 is particularly important for nuclear fragmentation
182
. In our 
study, the nuclei of H2O2-treated cells remained intact probably because caspase 3 did 
not cleave any substrate that maintains the nuclear membrane. Cleavage of Lamin 
A/C was found in STS-treated cells, but such cleavage was not found in H2O2-treated 
cells. What regulates caspase 3 from cleaving the substrates in altered nuclear event? 
A concentration-dependent effect of activated caspase 3 could be the key in cleaving 
the right substrates. In our study, H2O2-induced caspase 3 activation might be too low 
to cleave the Lamin A/C, therefore the nuclei remain intact. It has also been suggested 
that caspase 3 in the nuclei could be bounded to specific nuclear structure or 
scaffolding proteins, thereby preventing it to cleave the wrong substrates. 
 
While H2O2-induced activated caspase 3 was retained in the nucleus, STS-induced 
activated caspase 3 was relocated into the cytoplasm at 24h and 48h. One may 
hypothesize that this relocation could be a consequence of total disruption of the 
cytoplasmic-nuclear barrier. It has been shown that during apoptosis, the nuclear-
cytoplasmic barrier as well as the nuclear transport system was disrupted, leading to 
increased permeability of the nuclear pore. As a result, soluble proteins that are 





That is, in case of total disruption of the cytoplasmic-nuclear barrier, one should 
expect that the protein can be distributed evenly throughout the cells. However, we 
found that in apoptotic bodies, activated caspase 3 was only found in the cytoplasm. 
This suggests that activated caspase 3 can be re-transported out to the cytoplasm to 
cleave cytoplasmic substrates. Possible mechanisms could be directional diffusion of 
activated caspase 3 through the altered nuclear pore complexes from the nucleus to 
the cytoplasm, or activated caspase 3 could be actively transported out to the 
cytoplasm.  
 
Although the exact mechanism is not known, the cytoplasmic redistribution of 
activated caspase 3 could be important for apoptotic morphological change and 
apoptotic body formation
183,184
. The effector phase of apoptosis is characterized by 
sequential events starting with altered nuclear event, followed by cytoplasmic event 
and finally apoptotic body formation
185
. The cytoplasmic event involves caspase 3- 
mediated cytoskeletal reorganization and disintegration by cleavage of structural 
proteins such as gelsolin
183
, and caspase-3 mediated phosphatidylserine (PS) 
externalization
186
. This cytoplasmic structural change is critical to package the cells 
into membrane-bound apoptotic bodies that display PS on its outer surface. The 
formation of apoptotic bodies prevents leakage of cytoplasmic content to the 
surrounding tissues. This, together with its rapid phagocytosis by neighbouring cells, 
including macrophages and parenchymal cells, via recognition of the PS residue, 






4.1.3 Alternative pathway for alternative cell fate?  
The activation of effector caspases by the initiator caspases through the intrinsic 
pathway or extrinsic pathway is well established. When compared to the effector 
caspases, the initiator caspases are highly specific in substrate recognition. They 
cleave relatively few proteins other than their own proenzyme and their downstream 
effector caspases
188,189
. Therefore initiator caspases have specific roles, and we stand 
to reason that the initiator caspases have highest efficiency in cleaving their effector 
caspases. 
 
However, instead of the classical caspase cascade, why do cells sometimes decide to 
utilize an alternative, lower efficiency, pathway in activating caspase 3? We 
hypothesize that the alternative pathway might be one of the regulatory factors of 
caspase’s non apoptotic roles. As other protease may cleave caspase 3 less efficiently, 
the alternative pathway could be a way to control the level of activated caspase 3 in 
cells. Initiator caspases results in rapid, excessive effector caspase activation, suitable 
as a coarse control of caspase activation. However, a non caspase protease with lower 
efficiency can be used as fine control. This hypothesis was supported by Juan et al.’s 
study on the effect of thrombin on platelets and pancreatic acinar cells
172
. In their 
study, they reported a sequential and bimodal mode of caspase 3 activation by 
different concentration of thrombin. The early phase of caspase 3 activation induced 
by 1U/ml thrombin occurred independently of the initiator caspases 8, 9 and 10, and 
independently of mitochondrial-induced apoptosis
172
. The delayed phase of caspase 3 
activation was mediated by mitochondrial event and caspase 9. At the same time, 
apoptosis was activated. The early phase of caspase 3 activation can be achieved by 
using a low and physiological dose of thrombin (0.01U/ml). They also showed that 
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this caspase-independent, non apoptotic caspase activation was required for platelet 
aggregation and pancreatic amylase secretion
172
. In L6 myoblasts, when we increased 
the dose of H2O2 to 100µM and 150µM, cells underwent apoptosis. The activation of 
caspase 3 was at least 2 fold more than that induced by 50µM H2O2 (Appendix C).  
Preliminary findings show that in 100µM and 150µM H2O2-treated cells, activation of 
caspase 8 and 9 was detected. We speculated that caspase 3 activation in 100µM and 
150µM-treated cells were activated in a classical caspase cascade.  
 
There are also studies that reported alternative caspase 3 activation pathway leading 
to apoptosis. In P39 cells, the reduction in ATP resulted in lysosomal membrane 
permeabilization. The release of lysosomal enzymes was responsible for the 
activation of caspase 3, which was independent of the mitochondrial event and 
initiator caspases activation
190
. Another study showed that cisplatin induced caspase 3 
activation was mediated by p53 and this p53-mediated caspase 3 activation was 
independent of the initiator caspases and mitochondrial dysfunction
191
. On the other 
hand, classical caspase cascade has been observed in physiological, non-apoptotic 
condition. It was reported that caspase 3 required for the differentiation of muscle 
progenitor cells into myofibres was activated by caspase 9
192
. Interestingly, caspase 9 
activation was independent of mitochondrial event. These studies reinforce the idea 
that regulation of caspase 3 activation is coordinated by different regulatory 
mechanisms rather than conforming strictly to the caspase cascade model.  
 
In summary, we proposed that caspase 3 activation has a threshold level which 
dictates whether the cells are survive or undergo apoptosis. The classical caspase 
cascade pathway, with its rapid response and high efficiency is likely to serve as the 
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coarse control for caspase activation. Alternative activation pathways, such as the one 
we have proposed, probably act as fine control for the cell. The alternative activation 
pathways may be less efficient; however, a lower activation of caspase 3 that was 
sufficient for physiological function but insufficient for apoptotic function can be 
achieved. Furthermore, nuclear sequestration of caspase 3 could be an additional 
regulating mechanism of caspases’ roles; determining the consequences of caspase 3 




4.2 A lysosome-mediated pathway of caspase 3 activation 
In our study, we discovered an alternative pathway leading to caspase 3 activation 
involving lysosomal membrane permeabilization (LMP). H2O2 (50µM) activated 
caspase 3 in the absence of initiator caspases activation and mitochondrial event. We 
found that LMP release of cathepsin B and L was a crucial event in our study of 
caspase 3 activation. This cytosolic release of cathepsin B and L enabled the proteases 
to cleave and activate caspase 3. Using pharmacological inhibitors and molecular 
silencing approach, we identified four upstream candidates for LMP: iron, 
peroxynitrite, nitric oxide and p53. The inhibition of each of these four candidates 
inhibited both LMP and caspase 3 activation through pathways that are dependent and 
independent of each other’s. Our results suggest that, instead of the conventional 
mitochondria-mediated pathway of caspase activation, we proposed that lysosomes 
are the main player in our system. 
 
4.2.1     Lysosomal membrane permeabilization as a regulated event 
Lysosomal membrane permeabilization is a common event in both apoptosis and 
necrosis. Partial LMP, a limited release of lysosomal contents to the cytoplasm, 
activates the caspase cascade and result in apoptosis. On the other hand, massive LMP 
involves a generalized lysosomal rupture and uncontrolled release of lysosomal 
contents to the cytoplasm, leading to caspase-independent necrosis
193
. Many classical 


















The propagation of apoptosis via LMP is believed to proceed both dependently and 
also independently of mitochondrial event. The release of cathepsins from the 
lysosome is a major event after lysosomal membrane destabilization and is 
responsible for cleaving various protein substrates. The cleavage of the pro-apoptotic 
proteins Bid and Bax
196,200,201
 as well as the anti-apoptotic Bcl-2, Bcl-XL and MCL-
1
202
 by cathepsins result in mitochondrial event and subsequently activation of the 
caspase cascade. Figure 62 demonstrates how lysosome can participate in cell death, 
via caspase dependent or-independent pathway. 
 
Figure 62. Lysosomal membrane permeabilization as apoptosis mediator. LMP 
takes part in both caspase-dependent and –independent apoptosis. LMP is able to 
trigger the classical MOMP-caspase cascade, by cathepsins-mediated cleavage of the 
Bcl-2 family proteins such as Bid and Bax. During MOMP, the release of AIF from 
the mitochondria may also result in caspase-independent apoptosis. On the other 
hand, cytosolic release of cathepsins may result in caspase-independent apoptosis    
(AIF, apoptosis-inducing factor; CB, cathepsin B; CD, cathepsin D; Cyt. c, 
cytochrome c; LMP, lysosomal membrane permeabilization; MOMP, mitochondrial 






In our study, we presented an unconventional lysosomal pathway leading to caspase 3 
activation. There are two major differences between our pathway and the 
conventional lysosomal apoptotic pathway. Firstly, there was no apoptosis in our 
system, indicating that LMP does not necessarily result in apoptosis or cell death. 
Secondly, caspase 3 activation happened without the involvement of mitochondrial 
event.  
 
Although it seems that LMP is a potentially dangerous event to the cells, it could have 
a physiological function. The evidence of partial and massive LMP shows that LMP 
is actually a regulated event because the cells seem to respond to the stress intensities 
and decide how much LMP to induce. However, the intensity of LMP, whether 
classified as partial or massive, is usually dependent on the final outcome. Although 
the prevailing views favours linking LMP to cell death, this could be biased due to 
unreported negative results. The occurrence of so called “low LMP” was often 
ignored, because cells continue to survive without inducing apoptosis or necrosis. The 
intensity of LMP may be low but significant; however, this is usually not recognized 
or reported as LMP under the prevailing model. 
 
The most common method to measure LMP is by staining of cells with Acridine 
Orange. An increase in cytosolic green fluorescence indicates the occurrence of LMP. 
In our study, we found that LMP was induced at 2-4h, with an increase of average of 
105-120% from the control. The maximum of green fluorescence was detected at 4h. 
After 4h, the green fluorescence of Acridine Orange decreased and was decreased 
gradually to basal level by 12h. Essentially, this could mean that LMP is recoverable. 
Unlike MOMP, LMP is not a point of no return for apoptosis. This is best illustrated 
164 
 
by a study showing that different intensity of LMP could be triggered by different 
degree of photo-oxidative damage
204
. In the study, cells were irradiated with blue 
light for different length of time (2, 4, and 8min). Cells irradiated for 4 min recorded 
an increase in the Acridine Orange green fluorescence of 400-600% over the control, 
and were apoptotic. Cells irradiated for 2 min showed a “considerable less” increase 
in green fluorescence and were viable. Cells irradiated for 8 min showed a “more 
pronounced” increase in green fluorescence and were necrotic. The actual increase in 
green fluorescence for cells irradiated for 2 min was unreported because it was 
considered as a negative result. However, the so called “considerable less” Acridine 
Orange relocation could be a physiologically important event, because cells remained 
viable after blue light irradiation
204
.   
 
We proposed that, beside the intensities of LMP, the lack of mitochondrial event 
could be one of the key determinants of whether the cells undergo apoptosis or not. In 
our study, the absence of MOMP as well as caspase 9 activation could mean that 
LMP could bypass MOMP to be directly involved in effector caspase activation. Our 
study provided two new findings; firstly, LMP is not a point of no return for cell 
death. Unlike MOMP, LMP is not an all-or-none event; this is evident by the recovery 
of LMP in our study. We deduced that LMP could be regulated event and could even 
be physiological-relevant because the release of lysosomal content seems to be a 
controlled event. In this case, we believe that the intensity of stress could be an 
important factor to induce a low and reversible LMP. The regulation of LMP in turn, 




The actual mechanism of LMP is still largely unknown. Similarly, its regulatory 
mechanism remains elusive. It was reported that during partial LMP, not all 
lysosomes were permeabilized. The selectivity of LMP occurrence is dependent on 
the sizes and location of the lysosomes. For example, it has been shown that large 
lysosomes are more susceptible to LMP induction
205
. Also, the selectivity of 
lysosomal content release is still a mystery. As we have shown that LMP is reversible, 
it is more likely that lysosomal content release is mediated through specific pore 
formation rather than unspecific lysosomal membrane rupture. In addition, LMP can 
also be regulated via modulation of lysosome membrane stability. Studies have 
suggested Hsp70
206
 and lysosome-associated membrane proteins 1 and 2 (LAMP-1, -
2)
207
 can protect lysosomes from destabilization.   
 
4.2.2     Cathepsin B and L in caspase 3 activation 
The activation of caspases requires proteolytic processing of the proenzyme to active 
fragments that further oligomerize to form the active enzyme conformation.  
Activation of the initiator caspases involves autocatalytic intrachain cleavage with the 





, or induced conformation model
12
. Activation of effector caspases 
requires intrachain cleavage by the initiator caspases. In this study, we showed that, 
instead of the initiator caspases 8 and 9, Cathepsin B and L, were the upstream 
activators of caspase 3. LMP was induced by H2O2 treatment at 2-4h. This provides 
an opportunity of cytoplasmic translocation of cathepsin B and L, which then cleaved 




The involvement of cathepsins in caspase 3 activation, particularly in the context of 
apoptosis, has been reported
202,208,209
. It has been shown that mitochondrial event is 
indispensable for cell death initiated by LMP because cell death was inhibited by 
absence of Bax or Bak or over-expression of Bcl-2
210
. Also, purified cathepsins 
cleave Bid but not caspases in vitro
211
. These reports favour indirect activation of 
caspases through a LMP-MOMP functional hierarchy pathway. Nevertheless, there 
are opposing studies that support direct activation of caspases, in particular the 
effector caspases, by cathepsins. Studies have shown in vitro cleavage of caspase 3 by 
digitonin-treated lysosomal fractions and such cleavage was pH-dependent and was  
inhibited by cathepsin inhibitors
212,213
. In P39 cells treated with etoposide, apoptosis 
and caspase 3 was activated in the absence of MOMP and cytochrome c release
190
. 
The authors proposed that a lysosome pathway was activated as the activation of 
caspase 3 was suppressed by E64d (inhibitor for cathepsin and calpain), and a time-
dependent cytosolic release of cathepsin L was observed
190
. Besides caspase 3, direct 
activation of caspase 8 by cathepsin D in neutrophil apoptosis was also reported
214
. 
The contradictory and controversial results suggest that the pathway activated could 
be dependent on apoptotic trigger and cell type. The mechanisms by which cathepsins 





Figure 63. Lysosome-mediated pathway to caspase 3 activation. Upon lysosomal 
membrane permeabilization, cathepsins are released into the cytoplasm. In most 
studies, cathepsin-mediated activation of caspase 3 is based on their ability to induce 
MOMP by cleavage of the Bcl-2 family proteins, such as Bid. MOMP resulted in 
cytochrome c release followed by activation of caspase cascade and caspase 3 
activation. On the other hand, the direct cleavage of caspase 8 and caspase 3 by 
cathepsins has also been reported. (LMP: lysosomal membrane permeabilization; 
MOMP: mitochondrial outer membrane permeabilization)  
  
Instead of a single cathepsin, we found that both cathepsin B and L are involved in 
caspase 3 activation. Compared to caspases, cathepsins have less stringent specificity 
for substrate cleavage. Therefore, they have always been regarded as simple 
housekeeping proteases that take part in general proteolysis in the lysosome and have 
significant redundancy in substrate cleavage. Despite the redundancy in roles, recent 













important roles in specific biological function
215
. Furthermore, the deficiency or 




In our study, silencing of cathepsin B only partially inhibited caspase 3 activity, 
suggesting that both cathepsin B and L are important in caspase 3 activation in our 
system. Cathepsin B and L are ubiquitous and constitutively expressed
219
. It is 
believed that cathepsin B and L share partial overlapping substrate repertoires and 
play have redundancy roles in many biological functions
220-222
, although they may 
have different potency in substrate cleaving as regulated by stability in different 
pH
202
. Nevertheless, opposing actions of cathepsin B and L that support their non-
redundancy roles were also reported
223,224
.  Both cathepsin B and L have been shown 
to cleave caspases in vitro
137,213
, and cathepsin L was proposed to cleave caspase 3 
directly in vivo. Instead of unspecific proteolytic digestion, the cleavage of caspases 
by cathepsins results in caspases activation, probably due to the recognition of the 
canonical caspase recognition sites by cathepsins
225,226
.   
 
The involvement of both cathepsin B and L supports a redundancy roles of cathepsins 
in caspase activation. On the other hand, H2O2-induced caspase 3 activation was 
unaffected by inhibition of cathepsin G (Appendix D) and cathepsin D.  This 
suggested that the redundancy in role could be limited to the same protease family. 
Cathepsin B and L are cysteine proteases, while cathepsin G is serine protease and 
cathepsin D is an aspartate protease. It is not known if other cysteine cathepsin, e.g. 
cathepsin S, has a role to play in caspase 3 activation. This is yet to be investigated in 




4.3 Role of iron in H2O2-induced caspase 3 activation 
Iron is essential for cells proliferation and viability. It is an important component for 
key enzymes such as mitochondrial respiratory chain enzymes or essential cofactors 
for non-heme enzyme such as ribonucleotide reductase. Given the importance of iron, 
it is not surprising that iron deficiency could result in dysfunction in cellular 
processes, leading to decreased proliferation and apoptosis. It has been shown that 
iron deprivation by treatment with iron chelators could induce apoptosis in a caspase-
dependent manner
227,228
,  Nevertheless, it is also shown that iron overload can also 
induce apoptosis
229
. As a transition metal, iron can take part in redox reaction due to 
its ability to accept and donate electrons readily. Therefore, excess iron may be 
potentially dangerous to cells as they catalyse the production of ROS, e.g. OH• via 
Fenton reactions. The production of excessive ROS could have deleterious effect on 




In our study, we showed that iron was involved in both LMP and caspase 3 activation. 
Chelation of iron inhibited both LMP and caspase 3 activation. It was also found that 
only iron chelation at 0h could inhibit caspase activation. Also, extracellular iron was 
not required in the activation pathway. 
 
Based on this result, we postulated that H2O2 reacts with iron to give rise to a second 
ROS to initiate the whole system. While it is a known fact that H2O2 can react with 






. This is best illustrated in our system that HO-1 expression is not completely 
decreased by iron chelation. This suggests that the H2O2 signalling is more 
complicated than expected, there could be a parallel redox pathway (besides the iron 
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pathway) or there could even be multiple redox pathways which are activated 
concomitantly upon H2O2 treatment. Moreover, it is also not surprising that these 
pathways could crosstalk with each other at some points along the way. Nevertheless, 
it would appear that the iron-mediated pathway was directly linked to caspase 3 
activation in our system. This is outlined by the fact that iron chelation was able to 
completely prevent LMP and caspase 3 activation. 
 
The participation of iron at 0h was a crucial finding, because it eliminates the 
possibility of the iron-mediated reaction in directly inducing LMP, or directly acting 
on the upstream protease or caspase 3. It has been shown that intralysosomal iron 
could react with H2O2 to generate OH• that initiate peroxidation of lysosomal 
membrane, leading to LMP
140,198,237,238
. Also, iron chelation was shown to inhibit 
caspase activation by benzo[a]pyrene as this iron chelation directly inhibits the iron-
dependent protease lactoferrin
239
. However, this is unlikely the case in our study 
because iron chelation after 0h did not affect both LMP and caspase 3 activation, 
which happened at 2-4h, and 8-48h respectively.   
 
We therefore hypothesized that iron is only involved in the production of a second 
ROS. While the extracellular iron was of no importance, we deduced that the 
intracellular labile iron pool (LIP), a pool of chelatable and redox-active iron, is 
important in our system. Essentially, iron chelation at 0h quenches the availability of 
LIP to react with H2O2. It has been shown that the presence of iron was crucial for 
intracellular ROS generation upon drug treatment. For example, NADPH-dependent 
ROS formation after treatment with simvastatin alone or with simvastatin plus 





. Furthermore, gentamicin-induced ROS production and apoptosis 
was prevented in the presence of deferoxamine
241
.  On the other hand, iron-mediated 
ROS generation could be important not only in cell death pathway, but also in 
physiological-relevant conditions. For example, increased generation of free radicals 
or reactive oxygen intermediates in the presence of iron was reported to enhance the 




For our study, preliminary data in our lab have shown that iron chelation partially 
prevented the increase in DCF fluorescence. This, together with the effect of iron 
chelation on HO-1 expression, strongly supports that while iron is not a must for H2O2 





4.4 Role of peroxynitrite and nitric oxide in caspase 3 activation 
In our study, we showed that H2O2 treatment resulted in a sustained increase in ROS 
and RNS level. By using the ONOO
-
 decomposition catalyst, FeTPPS, LMP and 
caspase 3 activation was prevented. Beside FeTPPS, the nitric oxide chelator cPTIO 
was able to partially inhibit LMP and caspase 3 activation. On the other hand, LMP 
and caspase 3 activation was unaffected by the OH• chelator DMTU. We proposed 
that upon H2O2 treatment, the pathway leading to LMP and caspase 3 activation was 
redox-regulated, with peroxynitrite and nitric oxide being the main players involved.  
 
NO• is one of the most important second messengers in a variety of cellular functions, 




. One of the biological 
characteristics that makes NO• suitable as a second messenger is its ability to traverse 
across cell membranes rapidly to its targeted signalling complexes. Despite the high 
motility, NO• is a less reactive as compared to its free radical derivatives generated 
from NO•’s reaction with other oxygen radicals. ONOO-, generated by the reaction of 
NO• with O2•
-, is the most important free radical derivatives of NO•. ONOO- shares 
most of the same biological reaction of NO•, in direct and indirect reactions with 
cellular macromolecules, but with a higher reactivity. It is believed to be the 
important mediator of NO• in cell signaling pathway, as well as causing oxidative 
damage and cytotoxicity.   
 
In our study, we showed that both NO• and ONOO- are responsible for LMP 
induction and caspase 3 activation. Dual role of NO• has been reported as inhibitor or 
activator of apoptosis, depending on the concentration of NO•, free cysteine and the 
cell type
245,246. NO• and ONOO- are capable of s-nitrosylate caspase 3 on the its 
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active site cysteine, leading to its inactivation and inhibition of apoptosis
247,248
.  On 
the other hand, exogenous addition of NO• has been shown to induce apoptosis via a 
caspase-dependent mechanism
249. The dual effect of NO• on caspase activation is said 









 or nitric oxide-induced LMP is not reported. We deduced that they are 
capable of inducing LMP in a way similar to their ability to induce MOMP. NO• and 
ONOO
-
 was shown to activate the caspase cascade by induction of MOMP through 
multiple pathways, such as p53 and MAPK-mediated pathways. Direct modulation of 
the mitochondrial membrane stability by nitric oxide or ONOO
-
 has also been shown. 
A study has shown that high concentration of spermine NONOate (NO• donor) 





. Another study shows that when in high concentration, 
NO• can disrupt the mitochondrial membrane to release cytochrome c, which 
subsequently activates the caspase cascade and results in apoptosis
252
. Therefore, it is 
possible that NO• and ONOO- can also induce LMP by indirect or direct mechanisms 
similar to their induction of MOMP.  
 
While we have shown that ONOO
-
 and NO• were involved in our system, several 
questions remained unanswered: Firstly, how does a bolus dose of H2O2 lead to a 
sustained production of ONOO
-
 and NO•? Secondly, what is the effect of this 
sustained increase in ONOO
-




The sustained production of nitric oxide in our system could be due to an increased in 
nitric oxide synthase (NOS) activity. It has been shown that H2O2 treatment could 
result in short term and chronic increase of intracellular NO• level by modulating 
NOS activity and increased expression of NOS. In endothelial cells, H2O2 induced a 
rapid increase in the endothelial NOS (eNOS) serine 1177 phosphorylation and eNOS 
activation in a calcium-dependent manner
253
. Another group found that physiological 
concentrations of H2O2 activated eNOS, but not the neuronal NOS (nNOS), via a 
AMP-activated protein kinase and Akt-dependent pathway
254
. In this study, eNOS 
was phosphorylated at serine 1177 15 min after exposure to 10µM H2O2. On the other 
hand, long term activation of eNOS by H2O2 was mediated by increase gene 
transcription and increased mRNA stability
255
. Finally, in vivo study showed that rats 
administered intravenously with H2O2 showed increased eNOS and nNOS 




Of the three isoforms of NOS, only the neuronal NOS (nNOS) is expressed in L6 
myoblasts, the cell line used in our study (Appendix E). The three isoforms of NOS 
are encoded by different genes and are expressed in different cell types
257
. Given the 
similarity in protein structures, requirement for post-translational modification 
mechanisms and cofactors, similar mechanisms of H2O2 on eNOS (i.e. via increased 
phosphorylation or increased gene expression) could be applied on nNOS. We 
speculate that the initial increase in NO• level upon H2O2 treatment was due to 
increased nNOS activity by modulation of its phosphorylation status. Subsequently, 






 was involved in LMP and caspase 3 activation, it is not sure 
whether its production was sustained up to 48h, because the DCF dye also detects 
other ROS. Notably, FeTPPS and cPTIO has differential effect on LMP and caspase 3 
activation. FeTPPS efficiently inhibit both LMP and caspase 3 activation while 
inhibition by cPTIO is only partial. The question here is whether the ONOO
-
 and NO• 
mediated two separate pathways leading to caspase 3 activation. It is more likely that 
cPTIO was inefficient to chelate all intracellular NO•, and hence the partial inhibition 
of LMP and caspase 3 activation. In the presence of superoxide, NO• react quickly to 
generate ONOO
-
. Preliminary data in lab shows that, upon H2O2 treatment, there was 
an increase in dihydroethidium fluorescence staining, which is specific for 
superoxide. The production of superoxide upon H2O2 treatment could be mediated by 
NO•. It has been shown that NO• stimulated mitochondrial production of O2•-, H2O2 
and ONOO
-
 by inhibition of mitochondrial cytochrome c oxidase
258
. Also, all three 
NOS isoforms are known to produce O2•- as a by-product, although this usually 





In our system, although there was a sustained production of NO• and ROS, cells did 
not undergo apoptosis. The effect of this sustained oxidative stress is yet to be 
investigated. Although it is well known that ROS is a classical inducer of apoptosis 
and necrosis, chronic increase in ROS level has been associated with cell fate other 
than apoptosis (Figure 64). A few studies reported that pro-oxidant state of the cells 
favours cell survival. Sustained increased in intracellular ROS level “pre-conditioned” 
the cells to defence against apoptotic inducer, as ROS inhibit proteasome and Hsp70 
expression
260
. Another study showed that resveratrol inhibited H2O2-induced 
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apoptosis by increase in intracellular O2•
-
 concentration. They proposed that a pro-
oxidant state is non-conducive for apoptotic execution
261
. It was also found that cells 
that have sustained oxidative stress encountered premature senescence as evident by 
β-galactosidase staining, while not cytotoxic or cytostatic effect was observed262. In 
the long term, increased in ROS level may disrupt the redox homeostasis and 
signalling in cells, allowing the cells to develop flexible machinery that can adapt to 
and survive oxidative stress. The dysfunction of redox signalling, together with 
oncogene activation and loss of p53 allow the cells to evade apoptosis and 







Figure 64. ROS as important determinant of cell fates. Elevated intracellular ROS 
by exogenous stimuli or endogenous stress resulted in increased oxidative stress. In 
most cases, such increase in oxidative stress results in cellular senescence and cell 
death. The development of adaptation mechanisms, such as up-regulation of survival 
proteins, allows the cells to continue to survive. The increased oxidative stress can 
induce genomic instability, such as loss of function of the tumour suppressor p53. A 
vicious cycle is formed when loss of p53 function further contribute to ROS 
production and genomic instability, leading to abnormal cell proliferation, enhanced 
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4.5 Role of p53 in caspase 3 activation 
The role of p53 on caspase 3 activation is well established. Currently, there are two 
models of p53-mediated caspase 3 activation that centralized on the transcriptional-
dependent or –independent mechanisms of p53. In brief, the transcriptional-dependent 
mechanisms of p53 in apoptosis involves gene regulatory roles in up or down-
regulation of apoptotic-related genes. The transcriptional-independent mechanism 
requires physical association of cytoplasmic p53 with apoptotic-related proteins that 
activates or inactivates the protein’s function. Ultimately, both model result in 
MOMP, release of cytochrome c and caspase cascade activation.  
 
In our study, we showed that knocking down of p53 partially inhibited LMP and 
caspase 3 activation. The absence of MOMP in our system led us to propose a new 
pathway of p53 in caspase 3 activation through LMP and bypassing MOMP.  
 
4.5.1     p53 in LMP and caspase 3 activation 
A number of studies have demonstrated the role of LMP as in integral event in p53-
mediated apoptosis. In p53-mediated apoptosis, LMP was important as initiator event 
that triggered mitochondrial event and caspase cascade activation
197
. The inhibition of 
LMP also inhibited p53-mediated apoptosis, suggesting that LMP could be a common 
pathway and indispensible to p53-mediated apoptosis
197,263
 The importance of LMP 




The direct role of p53 on LMP induction was highlighted by studies showing that 
over-expression of p53 could trigger lysosomal membrane destabilization, and result 
in apoptosis
197
. It is natural to assume that the p53 induced-LMP could have bimodal 
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mechanisms via transcriptional-dependent or transcriptional-independent mode. 
Currently, the data favoured a transcriptional-independent role of p53 in LMP 
induction. It was discovered that the p53 protein translocates to the lysosomes during 
TNF-α induced apoptosis with the aid of Lysosome-associated apoptosis-inducing 
protein containing the pleckstrin homology and FYVE domains (LAPF) as an adaptor 
protein
265
. For this translocation, phosphorylation of p53 at serine 15 is of particular 
importance because LAPF recognized the phosphorylated homology. The co-
localization of phospho-p53 (ser15) to lysosomes was also shown to be crucial for 
LMP induction and cathepsins release in 
9
-tetrahydrocannabiol
266, or β-amyloid267– 
induced apoptosis. Furthermore, the transcriptional-deficient mutant of p53, 
p53R175H was able to induce apoptosis through LMP, confirming that p53 does not 




Nevertheless, there are studies that supported a transcriptional-dependent role of p53 
in LMP induction. For example, p53-dependent LMP induced by ultraviolet B 
treatment is accompanied by increase Puma and Noxa expression with absence of p53 
translocation at the lysosomal membrane. At the same time, both LMP and cathepsins 




PFT is a transcriptional inhibitor of p53 as it was shown to reduce the activation of 
p53-regulated genes, such as cyclin G, p21
CIP1/WAF1
 and mdm2 
154
 . It has been used in 
various studies that addressed the transcriptional dependent/independent role of p53 
in apoptosis
269,270
. The exact mechanisms of PFT-α on p53 inhibition remains elusive, 
although it was suggested that it could modulate the nuclear localization of p53 or the 
stability of nuclear p53
154
. Notably, PFT has also been shown to inhibit Heat Shock 
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and Glucocorticoid Signalling Pathways, suggesting it may target HSP complexes that 




In our study, LMP and caspase 3 activation was partially inhibited by molecular 
knock-down of p53. While PFT effectively decreased p53-mediated p21 expression, it 
had no effect on caspase 3 activation. This suggests that p53 induced caspase 3 
activation via a transcriptional-independent pathway. Furthermore, cytoplasmic 
phosphorylation of p53 on serine 15 was also detected at time points preceded LMP. 
We deduced that the cytoplasmic phospho-p53 (ser 15) might translocate to the 
lysosomal membrane and trigger LMP.   
 
It should be noted the increase in serine 15 phosphorylation was also detected with 
the nuclear pool of p53. As master gene of cell regulatory mechanism, p53 is tightly 
regulated through modulation of its localization, post-translational modification and 
protein stability. In normal, unstressed cells, p53 shuttle between the nucleus and 
cytoplasm and was maintained at low level through MDM2-dependent degradation
272
. 
The localization of p53 is variable, depending on the cell type
273
 and cell cycle 
phase
274,275
.  In L6 myoblasts, p53 localizes predominantly in the nucleus. Upon H2O2 
treatment, p53 protein is quickly stabilized and phosphorylated at serine 15. While we 
deduced that the cytoplasmic phospho-p53 (ser15) was important for LMP induction, 
we do not yet know the function of nuclear phospho-p53 (ser15). Serine 15 
phosphorylation is important for p53 protein stability as it reduces the binding of p53-
MDM2 complex. Serine 15 phosphorylation also enhances p53 transcriptional activity 





One important transcription target of p53 regulated by ser15 phosphorylation is p21, 




Interestingly, p21 expression remained unchanged after H2O2 treatment. Furthermore, 
H2O2-induced cell growth arrest was dependent on p53 but was independent of cell 
cycle regulation, as no arrest at any phase of the cell cycle was observed.  How p53 
exert its role in cell growth independently of p21 and cell cycle control is unknown. 
One possible explanation is that the cells experienced a generalized slow down in all 
cell cycle phases and hence an overall decrease in proliferation. Such idea was 
proposed by Tao et al., where they showed that hyposmosis induced growth arrest in 
two pancreatic (AsPC-1 and PaCa-2) carcinoma cell lines without any change to the 
cell cycle profile
279. They proposed that a “generalized cell cycle arrest” has occurred 
and this together with the formation of giant cells and cytoplasmic vacuolation in 
absence of apoptosis, are markers for a global cell cycle catastrophe. They also 
proposed that cell cycle catastrophe was due to decreased cell cycle-related proteins 
expression (Cdc2, cdk2, Cdk4, cyclin B1, and cyclin D3) as well as an overall 
decrease in cellular protein synthesis
279
.   
 
4.5.2     Redox-regulation of p53 
The activation of p53 by oxidative signal, either endogenous or exogenous has been 
reported. Microarray analysis of H2O2-responsive genes in H2O2-treated human cells 
share significant overlapping with p53 target genes
280
. During oxidative stress, sensor 
molecules detect oxidative stress in cells and trigger signalling transduction pathways 
which determine the effect of oxidative stress, whether it is reversible, or leading to 
cell cycle arrest, senescence or apoptosis. In oxidative stress-mediated DNA damage, 
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the Ataxia Telangiectasia Mutated (ATM) kinase is the major sensor that effect 
through p53-mediated signal transduction network
281
. Phosphorylation of p53 by 
ATM is crucial in initiating the p53-mediated DNA Damage Response. Besides 
ATM, other sensors that phosphorylate p53 include DNA-dependent protein kinase 
(DNA-PK)
281
 and the Ataxia Telangiectasia and Rad-3-related (ATR) kinase
282
. 
Together, ATM, DNA-PK and ATR constitute a myriad of p53 signalling 




Other than DNA damage stress-signalling pathway, increase in cellular oxidative 
stress can trigger the activation of the MAPK that subsequently activated p53 through 
phosphorylation at distinct residues. The three MAPK, c-Jun N-terminal kinase   
(JNK)
283
, Extracellular-signal-regulated kinases (ERK)
284
, and p38 MAPK
285
, have 
been shown to activate p53. It is important to note that activation of MAPK-p53 
signalling are not limited to ROS, but also common pathway in other stress-inducing 
pathway such as in induced-genotoxicity by ultra-violet B
286,287
. Also, although 
phosphorylation is important for p53 activation, there are other covalent post-









 , and methylation
292
 , that are critical to p53 protein stability and 





, are associated with oxidative stress.   
 
Notably, p53 itself is redox-sensitive due to the presence of conserved cysteine 
residues. These cysteine residues contain redox-sensitive thiol groups (-SH) and are 
prone to oxidative modification. The effect of such oxidative modification is variable 
and dependent on the residue modified and the type of modification
295
. Most of the 
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time, thiol oxidation of p53 induce conformational change that affects its DNA 
binding ability and hence transcriptional role, as well as p53 protein stability
296
. It has 
been suggested that redox modification of p53 is a mean of regulation of p53 
transcriptional function that allows it to preferential binding to individual target 
genes
297
. For example, changes in the Cys 277 redox state in the DNA binding 
domain of p53 decreases its binding to GADD45 but not to p21
297
.     
 
It is important to recognize that p53 does not just act downstream of ROS. Within the 
p53 signaling transduction network, cross talk between p53 and ROS pathway 
regulates redox balance and determine the cell fate. p53 could have anti-oxidant or 
pro-oxidant role depending on the degree of oxidative stress
145
. It was also suggested 
that how p53 responses to ROS depends on its protein level
295
. In response to 
different amount of stress, distinct p53 signalling pathways are activated, resulting in 
different cell fate. Under normal physiological condition or low level of oxidative 
stress, p53 exert its anti-oxidant role by transcriptionally activating several 
antioxidant genes, such as mammalian sestrin homologs 1 and 2, glutathione 
peroxidase 1 (GPX1), and mitochondrial SOD2
298-301
. The transcription of these genes 
is important to bring down or maintain the ROS level at a physiological level. On the 
other hand, high oxidative stress level results in p53 activation of pro-oxidant genes, 
such as PIG3 and proline oxidase
298,302
, or inhibition of anti-oxidant genes, such as 
SOD2 and Nrf2
303-305
. Furthermore, p53 induces the expression of pro-apoptotic 
genes, Noxa, Bax and Puma that mediate cytochrome c release from the mitochondria 






The overall effect of the pro-oxidant function of p53 is a further accumulation of ROS 
accumulation and this contribute to p53-induced cell death or cell senescence. Figure 




Figure 65. Context-dependent roles of p53 during oxidative stress. p53 could have 
anti-oxidant or pro-oxidant roles depending on the level of oxidative stress. By 
transcriptionally regulating distinct target genes, p53 is key determinant in cell fate 
during oxidative stress.  At basal or low level of oxidative stress, p53 induces the 
expression of anti-oxidant genes, to decrease ROS and promote cell survival. At high 
level of oxidative stress, p53 induces the expression of pro-oxidant genes while 
inhibits the expression of anti-oxidant genes. This results in increase ROS level and 







In our study, while we have shown that p53 is redox-dependent, the increase of DCF 
and DAF fluorescence was independent of p53. We also found that knock down of 
p53 further elevated the ROS level, suggesting that p53 may have an anti-oxidant role 
in our system. There is a question that remains unanswered: chelation of iron and 
ONOO
-
 inhibited p53 phosphorylation. It is not known whether it is due to a direct 
effect of ROS on p53 or through ROS-mediated signalling. We found that chelation 
of iron and ONOO
-
 could also inhibit γ-H2AX phosphorylation and prevented DNA 
damage (Appendix F). Therefore, p53 could be phosphorylated by ATM, or other 
DNA damage response protein. The MAPK are also possible candidates because their 
phosphorylation in the presence of oxidative/nitrosative stress is well known. 
Secondly, whether p53 has an anti-oxidant role and how it exerts this anti-oxidant 




4.6 A novel role of caspase 3 in lysosome biogenesis through regulation 
of TFEB 
Where caspase 3 is activated but apoptosis is not induced, it is of great interest what 
the role played by caspase 3. In our study, caspase 3 could play an important role in 
lysosomal biogenesis in absence of apoptosis. H2O2 treatment resulted in a dramatic 
increase in the numbers and sizes of lysosome. At the same time, we discovered that 
H2O2 induced the expression and nuclear localization of Transcriptional Factor for EB 
(TFEB), the master gene for lysosome biogenesis. The increase in lysosome 
biogenesis as well as TFEB regulation was found to be caspase 3-dependent. In view 
of the results, we proposed a novel role of caspase 3 in regulating lysosome 
biogenesis, through modulation of TFEB gene expression and localization.  
 
Current model of lysosome biogenesis by TFEB 
In the cells, lysosomes are specialized organelles that are critical in pH-dependent 
macromolecules degradation endocytic, heterophagy and autophagy pathways. 
Besides this catabolic function, lysosomes are also involved in other physiological 
functions, such as cholesterol homeostasis, plasma membrane repair, bone and tissue 
remodelling, pathogen defence and cell death
308
.  The process of lysosome biogenesis 
involves systematic co-expression and co-localization of lysosome soluble and 
membrane proteins that integrated with the cellular endocytic pathway
308
. 
Furthermore, lysosomal functions and compositions vary depending on cell type, age, 
and exogenous stimulus
309
. Therefore, it has been postulated that lysosome biogenesis 




In fact, it is recently discovered that lysosome biogenesis is controlled by a master 
gene TFEB
155
. TFEB is a basic Helix-Loop-Helix leucine zipper transcription factor 
that belongs to the microphatalmia-transcription factor E family
310
. It has been shown 
that TFEB over-expression increased lysosomes size and numbers per cells, as well as 
the transcription of lysosomal targeted genes
155
. Among the lysosomal targeted genes 
regulated by TFEB are lysosome resident proteins, such as lysosomal hydrolases, 
cathepsins, lysosomal membrane proteins, and components of the vacuolar H+-
ATPase. These proteins carry out important functions of lysosomes, such as substrate 
degradation, lysosomal acidification
155,311
. The role of TFEB in autophagy was 
demonstrated when knock down of TFEB inhibited autophagy while over expression 
increased the number of autophagosomes
312
. Autophagy-related genes, including 
RRAGC and UVRAG, which are non lysosomal proteins and are key factors regulators 
of autophagy
313,314




It is shown that the phosphorylation status of TFEB is critical for its regulation
312
. 
Under physiological condition, phosphorylation of serine 142 is critical for the 
sequestration of TFEB in the cytoplasm and to keep the protein in inactive state
312,315
. 
Upon nutrient deprivation, serine 142 of TFEB is dephosphorylated and this enables 
TFEB to translocate to the nucleus to initiate its gene transcription. Currently, two 





ERK2-TFEB complex was found in starved cells, but not normal cells. Knock down 
of ERK2 induced TFEB nuclear translocation, while constitutive activated ERK 
pathway resulted in down-regulation of TFEB target gene expression during 
starvation
312
. The mTOR model depends on the ability of TFEB to shuffle between 
lysosomal compartment and cytoplasm compartment. When TFEB binds to the 
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lysosomal surface, it is phosphorylated by mTOR complex 1 (mTORC1), which is 
held in place by the RagGTPase and Ragulator complex
315
. In case of nutrient 
deprivation and lysosomal stress, RagGTPase is inactivated, resulting in mTORC1 
dissociation from lysosome. Displace mTORC1 is unable to re-phosphorylate TFEB, 
and this results in translocation of unphosphorylated TFEB into the nucleus. This 
model links TFEB regulation with lysosomal stress where lysosome itself acts as a 
sensor for its own defect and activates the repair of defective nutrient and/or pH status 
of the lysosome
315








Figure 66. Models depicting regulation of TFEB localization and activation by 
ERK and mTOR. In both models, the phosphorylation on TFEB residue serine 142 
is of great importance for its cytoplasmic sequestration. (A) The MEK-ERK pathway 
regulates TFEB by ERK-mediated phosphorylation. Upon starvation, shut down of 
MEK-ERK pathway resulting in dephosphorylation of TFEB and its nuclear 
translocation. (B) Under physiological condition, mTORC1 is recruited by V-ATPase 











































surface. TFEB binds to mTORC1 and is re-phosphorylated. Upon starvation and 
lysosomal stress, the Rag complex is inactivated, resulting in dissociation of 
mTORC1 from the lysosome surface. Dissociated mTORC1 is unable to 
phosphorylate TFEB. This results in TFEB dephosphorylation and translocation into 
the nucleus. (Adapted from Settembre 2011
312




How caspase 3 regulates TFEB is unknown. We speculate that caspase 3 could be 
involved in cleaving one of the members of the mTORC1 associated with TFEB, 
leading to complex dissociation and TFEB dephosphorylation. Alternatively, caspase 
3 could be disrupting the upstream pathway leading to mTOR and ERK activation. 
Caspase 3 cleavage of mTORC1 or ERK is unreported. However, caspase 3 could 
cleave MEK, the upstream kinase of ERK
316
, or Kinase suppressor of Ras1 (KSR1), 
the protein scaffold that facilitates ERK pathway
317
. While the regulation of TFEB 
seems to be a cytoplasmic event, it should be noted that H2O2-induced activated 
caspase 3 is sustained in nucleus, hence a nuclear substrate should be cleaved that 
leads to dephosphorylation of TFEB. How a nuclear-localized caspase 3 is able to 
regulate a cytoplasmic event is again a challenging question that remains without an 
answer. We believe this is the first study reporting on caspase 3’s role in lysosome 
biogenesis. 
 
It should be noted that H2O2 has been shown to be involved in the regulation of PI3K-
AKT-mTOR pathway in a number of studies. H2O2 has been shown to inhibit mTOR 
through AMPKα activation318 or through a Bcl-2/E1B 19kDa interacting protein 3 
(BNIP3)-dependent pathway
319
, leading to autophagy or cell death. On the other hand, 
it has also been shown that activation of the PI3K-AKT-mTOR pathway is crucial in 
H2O2-induced mitogenic signalling
320
. Therefore, H2O2 could regulate mTOR through 
multiple pathways resulting in different cellular outcome. Correspondingly, H2O2-
191 
 
induced TFEB activation and lysosome biogenesis could be caspase-dependent, or 
caspase-independent, as a result of mTOR suppression by H2O2.  
  
In our study, we found increase in lysosomal volume increase after 8h and cathepsin 
B expression after 24h. This is in correlation to the increased expression and nuclear 
localization of TFEB, However, the implication of increased TFEB signalling 
pathway and lysosome biogenesis in our system is unknown. It has been shown that in 
the cells of Lysosome Storage Disorders mouse model, TFEB has a predominant 
nuclear localization
155
. This indicates that the TFEB signalling is important in the 
intralysosomal storage of undegraded molecules, because activation of TFEB enhance 
lysosome-dependent degradation pathways
155
. On the other hand, increase in 
lysosome and autophagosome numbers is associated with senescence and autophagy 
respectively. Senescence associated-β-gal activity that is usually detected in senescent 
cells is attributed to increased lysosomal-β-galactosidase activity321. Also, TFEB 
nuclear translocation is associated with the induction of autophagy
312
. In our system, 
H2O2 treatment does not induce apoptosis, but could be potentiating the cells to 
premature senescence or autophagy. Future work regarding our study could include 
biochemical analysis of markers of senescence and autophagy. This is essential in 





In summary, we have identified an unconventional pathway of caspase 3 activation 
during H2O2-induced oxidative stress. By comparing the activation of caspase 3 in our 
system to that induced by the classical apoptotic trigger, STS, we proposed three 
possible mechanisms for caspase’s non-apoptotic roles regulation: a threshold for 
caspase 3 activation, sustained nuclear localization of activated caspase 3, and an 
alternative pathway for caspase 3 activation.  
 
Also, we have presented a lysosome-mediated pathway of caspase 3 activation that 
involves ROS and p53. Starting with a redox reaction involving iron, the H2O2-
induced caspase 3 activation involved ONOO
-
, NO•, and p53 as the upstream signals 
to induce LMP. The activation of p53 was peroxynitrite-dependent but nitric oxide-
independent. We postulated that LMP could be induced directly by ONOO
-
 and/or 
NO•, and it could also be induced by p53 in a peroxynitrite-dependent manner. LMP 
resulted in cathepsin B and L release into the cytoplasm. Cathepsin B and L activated 
caspase 3 and activated caspase 3 was translocated into the nucleus.  
 
Lastly, we discovered a novel role of caspase 3 in lysosome biogenesis. For the first 
time, caspase 3 was found to regulate the gene expression as well as the nuclear 
localization of TFEB, the master gene for lysosome biogenesis. Although we do not 
yet know the outcome of this caspase 3-mediated TFEB gene regulation, we postulate 
that it may potentiate the cells to cellular senescence or autophagy. The discovery of 
caspase 3 role in lysosome biogenesis adds on to its non-apoptotic physiological role. 
How caspase 3 regulate TFEB gene expression and nuclear localization is another 
193 
 
story that is of great interest as this provides new insides to caspase function and 
regulation.   
 
The pathway of H2O2-induced caspase 3 activation is presented in Figure 67. 
 
 
Figure 67. Summary of H2O2-induced caspase 3 activation. Upon H2O2 treatment 
in the presence of iron, ONOO
-
 and NO• were produced. At the same time, p53 was 
phosphorylated in ONOO
-/NO• – dependent manner. Together, ONOO-, NO•, and 
p53 could induce LMP at 2-4h. This resulted in cathepsin B and L release from the 
lysosome and activates caspase 3. After activation, cleaved caspase 3 was translocated 
into the nucleus. While not inducing apoptosis, caspase 3 was found to regulate 
lysosome biogenesis through regulation of TFEB gene expression and localization. 
The final outcome of caspase 3 activation and increased lysosome biogenesis is yet to 
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Appendix A. H2O2 treatment resulted in DNA damage. L6 myoblasts were treated 
with 50μM H2O2 for 1h. (A) After fixation, cells were stained with antibody specific 
to γ-H2AX, a DNA double strand break marker, in green. Nuclei were stained blue 
with Hoechst 34580. (B) Comet tail moment measurements using alkaline comet 
assay. (Courtesy of Gireedhar Venkatachalam)  
 








Appendix B. Effect of H2O2 and STS treatment on classic caspase 3 substrates 
cleavage. L6 myoblasts were treated with 25, 50, 150 μM H2O2 or  1μM STS.  Cells 
were harvested at 9 hours and 24 hours for Western Blot analysis of cleavage of 
structural proteins: Gelsolin and Lamin A/C, and DNA damage repair protein: PARP. 




















































Appendix C. Effect of different dose of H2O2 on caspase 3 activity and cell 
morphology. Cells were treated with increasing dose of H2O2 for 24 hours. (A) Cells 
were harvested for caspase 3 activity assay. The data are the means of three 
independent experiments ± S.E.M. (B) Cell morphology was observed under a phase 





































Appendix D. Caspase 3 activation upon H2O2 treatment was independent of 
cathepsin G. Cells were pre-treated with 20 or 50µM cathepsin G inhibitor I before 
exposure to 50µM H2O2. At 24h post-H2O2 treatment, cells were harvested for 




Appendix E. nNOS is expressed in L6 myoblasts. Cells were treated with 50µM 
H2O2 for 24 hours and were harvested for Western Blot analysis of NOS isoforms. 














































Appendix F. Phosphorylation of γ-H2AX was inhibited by iron and ONOO- 
chelation. Cells were pre-treated with iron chelator, phenanthroline (Phenan), and 
peroxynitrite decomposition catalyst, FeTPPS for 2 hours before exposure with 50µM 
H2O2. At 1h post-H2O2 treatment, cells were harvested for Western Blot analysis of γ-
H2AX. (DMSO: vehicle control). (Courtesy of Gireedhar Venkatachalam) 
  
Medium DMSO Phenan FeTPPS
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